[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "falcon",
    "section": "",
    "text": "Implementation of FDA Safety Tables and Figures\n\n\n\n\n\n\n\n\n\nWhat is falcon?\nThe falcon initiative is an industry collaborative effort under pharmaverse that brings together pharmaceutical companies with the aspiration of building and open-sourcing a catalog of harmonized tables, listings, and graphs (TLGs) in clinical study reporting. Leveraging existing open-source R packages, falcon aims to simplify the process of output review, comparison, and meta-analyses, fostering efficient communication among stakeholders in the pharmaceutical sector while aligning with CDISC’s ARD/ARM effort at the same time. Drawing inspiration from the FDA Standard Safety Tables and Figures Integrated Guide, we develop open-source templates. Future plans entail expanding the catalog of templates through continuous collaboration from participating companies and inviting wider industry to promote harmonization of TLGs for clinical reporting.\n\nGetting Started\nTemplate Library Index \n \n\n\nOur Collaboration Journey\nFAQ\n\nUpcoming Talks & Presentations\nNo upcoming talks or presentations currently scheduled. Stay tuned!\nSee resources from past talks & presentations here.\nContributors\n\n\n\n\n\n\n\n\nEmily de la Rua\nAbinaya Yogasekaram\n\n\n\n\n\n\n\n\n\nJessica Knizia\nYoshito Koujin\nKorbinian Matthias\n\n\n\n\n\n\n\n\n\nAlex Assuied\nHuan Lu\n\n\n\n\n\n\n\n\n\nYichen Wang\nYuye Wang"
  },
  {
    "objectID": "quarto/about.html",
    "href": "quarto/about.html",
    "title": "About the Project",
    "section": "",
    "text": "The falcon project is a product of industry collaboration to encourage the development of shared code, expertise, knowledge, and products.\nIn the near future, the goal is to develop functionality to create regulatory reporting tables suitable for FDA filing. The long-term objective of this collaboration is to develop an R package that can be used industry wide - developing a cross-industry standard and reducing manual work from a reporting perspective."
  },
  {
    "objectID": "quarto/about.html#our-collaboration-journey",
    "href": "quarto/about.html#our-collaboration-journey",
    "title": "About the Project",
    "section": "Our Collaboration Journey",
    "text": "Our Collaboration Journey\nCurrent collaborators are from Roche, Sanofi, Boehringer Ingelheim, and Moderna. Developers are connected via Slack and GitHub for the creation of shared solutions using publicly available analysis packages for R. Developers are invited to browse the falcon project repository and related packages for insight into our template designs.\n\nJoining as a Collaborator\nAs always we invite further collaboration and welcome additional companies to join the falcon initiative and contribute to the project. Please feel free to contact any of the repository maintainers for more information and check out the section below for more information on joining the project as a developer.\n\nInformation for Developers\nAs a pharmaverse collaboration, we invite any interested developers to join the falcon team and contribute to template development. To onboard as a developer, please reach out to one of the falcon Product Owners (Vincent Shen, Freeman Wang, Juergen Boehl, Lian Lin) to receive access to the falcon GitHub repository.\nTasks are assigned and prioritized via issues on our GitHub project board and worked on in development branches. Members of the team will review each other’s code and make suggestions before new functions and features are incorporated into the package.\nWe encourage the smart developer to familiarize themselves with the following packages as they contain functions leveraged by falcon for table creation:\n\nrtables: Table creation\ntern: Clinical trials analysis functions\nrandom.cdisc.data: Synthetic randomized CDISC datasets"
  },
  {
    "objectID": "quarto/index-templates.html",
    "href": "quarto/index-templates.html",
    "title": "Template Library Index",
    "section": "",
    "text": "FDA Tables\n\nFDA Table 2 – Baseline Demographic and Clinical Characteristics, Safety Population, Pooled Analyses\nFDA Table 3 – Patient Screening and Enrollment, Trials A and B\nFDA Table 4 – Patient Disposition, Pooled Analyses\nFDA Table 5 – Duration of Treatment Exposure, Safety Population, Pooled Analyses\nFDA Table 6 – Overview of Adverse Events, Safety Population, Pooled Analyses\nFDA Table 7 – Deaths, Safety Population, Pooled Analyses\nFDA Table 8 – All Individual Patient Deaths, Safety Population, Pooled Analyses\nFDA Table 9 – Patients With Serious Adverse Events by System Organ Class and Preferred Term, Safety Population, Pooled Analyses\nFDA Table 10 – Patients With Serious Adverse Events by System Organ Class and FDA Medical Query (Narrow), Safety Population, Pooled Analyses\nFDA Table 11 – Patients with FDA Medical Query (Narrow) Leading to Treatment Discontinuation, Safety Population, Pooled Analyses\nFDA Table 12 – Patients With Adverse Events Leading to Treatment Discontinuation by System Organ Class and Preferred Term, Safety Population, Pooled Analyses\nFDA Table 13 – Patients With Common Adverse Events Occurring at &gt;=X% Frequency, Safety Population, Pooled Analyses\nFDA Table 14 – Patients With Adverse Events by System Organ Class and FDA Medical Query, Safety Population, Pooled Analyses\nFDA Table 15 – Patients With Adverse Events by Male-Specific FDA Medical Query (Narrow) and Preferred Term, Male Safety Population, Pooled Analyses\nFDA Table 16 – Patients With Adverse Events by Male-Specific FDA Medical Query (Broad) and Preferred Term, Male Safety Population, Pooled Analyses\nFDA Table 17 – Patients With Adverse Events by Female-Specific FDA Medical Query (Narrow) and Preferred Term, Female Safety Population, Pooled Analyses\nFDA Table 18 – Patients With Adverse Events by Female-Specific FDA Medical Query (Broad) and Preferred Term, Female Safety Population, Pooled Analyses\nFDA Table 20 – Adverse Events of Special Interest Assessment, Safety Population, Pooled Analysis (or Trial X)\nFDA Table 21 – Overview of Serious Adverse Events1 by Demographic Subgroup, Safety Population, Pooled Analysis (or Trial X)\nFDA Table 32 – Percentage of Patients With Maximum Diastolic Blood Pressure by Category of Blood Pressure Postbaseline, Safety Population, Pooled Analysis\nFDA Table 33 – Percentage of Patients Meeting Specific Hypotension Levels Postbaseline, Safety Population, Pooled Analysis\nFDA Table 34 – Patients With Serious Adverse Events by System Organ Class, FDA Medical Query (Narrow), and Preferred Term, Safety Population, Pooled Analysis (or Trial X)\nFDA Table 35 – Patients With Adverse Events1 by System Organ Class, Safety Population, Pooled Analysis (or Trial X)\n\n\n\n\nFDA Figures\n\nFDA Figure 1 – Time to Permanent Discontinuation of Study Drug, Safety Population, Pooled Analyses"
  },
  {
    "objectID": "quarto/getting_started.html",
    "href": "quarto/getting_started.html",
    "title": "Getting Started",
    "section": "",
    "text": "Environment Setup and Package Installation\nEnvironment Setup\nPlease ensure that R version 3.6 or higher is installed on your computer. This is required to install the falcon package and its dependencies. You can check your current version of R by running sessionInfo() within the R console.\nInstalling Package Dependencies\nThe falcon package requires several packages available on CRAN.\nTo use the falcon package, ensure you have these necessary package dependencies installed by running the following code:\n\nif (!require(\"formatters\")) install.packages(\"formatters\")\nif (!require(\"rtables\")) install.packages(\"rtables\")\nif (!require(\"rlistings\")) install.packages(\"rlistings\")\nif (!require(\"remotes\")) install.packages(\"remotes\")\nif (!require(\"tern\")) install.packages(\"tern\")\n\nOptionally, to run the examples provided within the falcon package and on this site you can also install the synthetic CDISC data package from GitHub, which contains the example datasets, by running the following:\n\nif (!require(\"random.cdisc.data\")) remotes::install_github(\"insightsengineering/random.cdisc.data@*release\")\n\nFor more information on these packages, see the Additional Resources section below.\nInstalling the falcon Package\nTo install the falcon package, run the following line of code:\n\nif (!require(\"falcon\")) remotes::install_github(\"pharmaverse/falcon\")\n\nLoading Data\nThe table functions provided by falcon are designed to work with any datasets which adhere to CDISC standards. If you have access to CDISC data, load this into your R environment as usual to use when generating tables.\nIf you do not have access to CDISC data, or want to run the examples provided within the package, you can use the random.cdisc.data package to load a selection of datasets containing example synthetic randomized CDISC data. Datasets are stored in the package by name, prefixed by the letter \"c\" (for “cached”). For example, after loading the random.cdisc.data package you can access an ADSL dataset by running cadsl, or ADAE with cadae. This data is loaded in where necessary as part of the provided examples.\nTemplate Navigation\nA list of all templates currently available in falcon is provided in the Template Library Index, with tables designed based on the FDA Standard Safety Tables and Figures: Integrated Guide.\nEach template provided is associated with a function available within the falcon package, and contains 4 sections:\n\n\nSpec. Screenshot: This tab provides a screenshot of the given table coming from the FDA Standard Safety Table and Figures document.\n\n\n\n\n\n\n\nTable: This tab displays the output table corresponding to the screenshot in the previous tab, generated using the associated falcon table function. You can expect a similar output table when using the table function with your own data, depending on pre-processing and the customizations that you apply via the table function parameters.\n\n\n\n\n\n\n\nTable Setup: This tab provides the code used to generate the example table displayed in the previous tab, including the loading of necessary libraries and example datasets, and any pre-processing steps applied prior to generating the table.\n\n\n\n\n\n\n\nFunction Details: This tab includes details on the table-generating function used for this template. Table functions use the naming convention make_table_XX() where XX is the table number taken from the FDA Standard Safety Table and Figures document (preceded by a 0 if the number is a single digit). Any required variables for the input datasets are listed along with a description of all function arguments. This information is mirrored by the function’s help page accessible within R (i.e. ?make_table_XX).\n\n\n\n\n\n          A link to the function’s source code can be found at the bottom of the page in this tab:\n\n\n\n\nCreating Tables\nThere are many table-generating functions available within the falcon package, each of which is used to generate a different FDA standard safety table using R. These functions create rtables table objects which can then be further customized, paginated, etc. if required using functions from the rtables package.\nUsing the Table Functions\nTo use the table functions you will need to load the falcon package and then call the appropriate table function. For example, to create FDA Safety Table 2, you can run the following code:\n\nlibrary(dplyr)\nlibrary(falcon)\n\n# Data pre-processing - ensure all necessary variables are present in the data\nadsl &lt;- random.cdisc.data::cadsl %&gt;%\n  mutate(AGEGR1 = as.factor(case_when(\n    AGE &gt;= 17 & AGE &lt; 65 ~ \"&gt;=17 to &lt;65\",\n    AGE &gt;= 65 ~ \"&gt;=65\",\n    AGE &gt;= 65 & AGE &lt; 75 ~ \"&gt;=65 to &lt;75\",\n    AGE &gt;= 75 ~ \"&gt;=75\"\n  )) %&gt;% formatters::with_label(\"Age Group, years\")) %&gt;%\n  formatters::var_relabel(AGE = \"Age, years\")\n\n# Create table\ntbl &lt;- make_table_02(df = adsl)\ntbl\n\n                                                  A: Drug X            B: Placebo         C: Combination      Total Population \nCharacteristic                                     (N=134)              (N=134)              (N=132)              (N=400)      \n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nSex                                                                                                                            \n  F                                                79 (59%)            82 (61.2%)            70 (53%)           231 (57.8%)    \n  M                                                55 (41%)            52 (38.8%)            62 (47%)           169 (42.2%)    \nAge, years                                                                                                                     \n  Mean (SD)                                       33.8 (6.6)           35.4 (7.9)           35.4 (7.7)           34.9 (7.4)    \n  Median (Min - Max)                          33.0 (21.0 - 50.0)   35.0 (21.0 - 62.0)   35.0 (20.0 - 69.0)   34.0 (20.0 - 69.0)\nAge Group, years                                                                                                               \n  &gt;=17 to &lt;65                                     134 (100%)           134 (100%)          131 (99.2%)          399 (99.8%)    \n  &gt;=65                                                0                    0                 1 (0.8%)             1 (0.2%)     \nRace                                                                                                                           \n  ASIAN                                           68 (50.7%)            67 (50%)            73 (55.3%)           208 (52%)     \n  BLACK OR AFRICAN AMERICAN                       31 (23.1%)           28 (20.9%)           32 (24.2%)           91 (22.8%)    \n  WHITE                                           27 (20.1%)           26 (19.4%)           21 (15.9%)           74 (18.5%)    \n  AMERICAN INDIAN OR ALASKA NATIVE                  8 (6%)             11 (8.2%)             6 (4.5%)            25 (6.2%)     \n  MULTIPLE                                            0                 1 (0.7%)                0                 1 (0.2%)     \n  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER           0                 1 (0.7%)                0                 1 (0.2%)     \nEthnicity                                                                                                                      \n   NOT REPORTED                                    6 (4.5%)            10 (7.5%)            11 (8.3%)            27 (6.8%)     \n  HISPANIC OR LATINO                              15 (11.2%)           18 (13.4%)           15 (11.4%)            48 (12%)     \n  NOT HISPANIC OR LATINO                         104 (77.6%)          103 (76.9%)          101 (76.5%)           308 (77%)     \n  UNKNOWN                                          9 (6.7%)             3 (2.2%)             5 (3.8%)            17 (4.2%)     \nCountry                                                                                                                        \n  CHN                                             74 (55.2%)           81 (60.4%)           64 (48.5%)          219 (54.8%)    \n  USA                                             10 (7.5%)            13 (9.7%)            17 (12.9%)            40 (10%)     \n  BRA                                             13 (9.7%)             7 (5.2%)            10 (7.6%)            30 (7.5%)     \n  PAK                                              12 (9%)              9 (6.7%)            10 (7.6%)            31 (7.8%)     \n  NGA                                               8 (6%)              7 (5.2%)            11 (8.3%)            26 (6.5%)     \n  RUS                                              5 (3.7%)              8 (6%)              6 (4.5%)            19 (4.8%)     \n  JPN                                              5 (3.7%)              4 (3%)              9 (6.8%)            18 (4.5%)     \n  GBR                                               4 (3%)              3 (2.2%)             2 (1.5%)             9 (2.2%)     \n  CAN                                              3 (2.2%)             2 (1.5%)             3 (2.3%)              8 (2%)      \n\n\nThe above table is created using the default settings. You can customize tables by specifying function parameter values to set input data, variables to include in the table, table annotations, etc.\nTable Customization\nEach template takes several arguments that can be set to generate a table that meets your requirements. A brief overview of the parameters for each template is provided in the Function Details section of each table template page (see the Function Details section above) and the function’s help page within R (i.e. ?make_table_XX), with many of these parameters being standard across table functions.\nTo customize the output table, you can modify the values of these arguments as per your requirements. For example, table 2 can be customized as follows:\n\nadvs &lt;- random.cdisc.data::cadvs %&gt;%\n  filter(AVISIT == \"BASELINE\", VSTESTCD == \"TEMP\") %&gt;%\n  select(\"USUBJID\", \"AVAL\")\n\nanl &lt;- left_join(adsl, advs, by = \"USUBJID\") %&gt;% tern::df_explicit_na()\n\ntbl &lt;- make_table_02(\n  df = anl,\n  vars = c(\"SEX\", \"AGE\", \"RACE\", \"COUNTRY\", \"AVAL\"),\n  lbl_vars = c(\"Sex\", \"Age, years\", \"Race\", \"Country of Participation\", \"Baseline Temperature (C)\"),\n  lbl_overall = \"Total\\nPopulation\",\n  na_rm = TRUE,\n  annotations = list(\n    title = \"Table 2. Baseline Demographic and Clinical Characteristics Safety Population, Pooled Analyses\",\n    main_footer = \"Source: [include Applicant source, datasets and/or software tools used].\",\n    prov_footer = paste(\n      \"Abbreviations: N, number of patients in treatment arm;\",\n      \"n, number of patients with given characteristic; SD, standard deviation\"\n    )\n  )\n)\ntbl\n\nTable 2. Baseline Demographic and Clinical Characteristics Safety Population, Pooled Analyses\n\n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\n                                                                                                                   Total       \n                                                  A: Drug X            B: Placebo         C: Combination         Population    \nCharacteristic                                     (N=134)              (N=134)              (N=132)              (N=400)      \n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nSex                                                                                                                            \n  F                                                79 (59%)            82 (61.2%)            70 (53%)           231 (57.8%)    \n  M                                                55 (41%)            52 (38.8%)            62 (47%)           169 (42.2%)    \nAge, years                                                                                                                     \n  Mean (SD)                                       33.8 (6.6)           35.4 (7.9)           35.4 (7.7)           34.9 (7.4)    \n  Median (Min - Max)                          33.0 (21.0 - 50.0)   35.0 (21.0 - 62.0)   35.0 (20.0 - 69.0)   34.0 (20.0 - 69.0)\nRace                                                                                                                           \n  ASIAN                                           68 (50.7%)            67 (50%)            73 (55.3%)           208 (52%)     \n  BLACK OR AFRICAN AMERICAN                       31 (23.1%)           28 (20.9%)           32 (24.2%)           91 (22.8%)    \n  WHITE                                           27 (20.1%)           26 (19.4%)           21 (15.9%)           74 (18.5%)    \n  AMERICAN INDIAN OR ALASKA NATIVE                  8 (6%)             11 (8.2%)             6 (4.5%)            25 (6.2%)     \n  MULTIPLE                                            0                 1 (0.7%)                0                 1 (0.2%)     \n  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER           0                 1 (0.7%)                0                 1 (0.2%)     \nCountry of Participation                                                                                                       \n  CHN                                             74 (55.2%)           81 (60.4%)           64 (48.5%)          219 (54.8%)    \n  USA                                             10 (7.5%)            13 (9.7%)            17 (12.9%)            40 (10%)     \n  BRA                                             13 (9.7%)             7 (5.2%)            10 (7.6%)            30 (7.5%)     \n  PAK                                              12 (9%)              9 (6.7%)            10 (7.6%)            31 (7.8%)     \n  NGA                                               8 (6%)              7 (5.2%)            11 (8.3%)            26 (6.5%)     \n  RUS                                              5 (3.7%)              8 (6%)              6 (4.5%)            19 (4.8%)     \n  JPN                                              5 (3.7%)              4 (3%)              9 (6.8%)            18 (4.5%)     \n  GBR                                               4 (3%)              3 (2.2%)             2 (1.5%)             9 (2.2%)     \n  CAN                                              3 (2.2%)             2 (1.5%)             3 (2.3%)              8 (2%)      \nBaseline Temperature (C)                                                                                                       \n  Mean (SD)                                       36.7 (1.0)           36.6 (1.1)           36.5 (1.0)           36.6 (1.0)    \n  Median (Min - Max)                          36.7 (34.0 - 39.3)   36.6 (33.6 - 38.9)   36.5 (34.2 - 38.9)   36.6 (33.6 - 39.3)\n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\n\nSource: [include Applicant source, datasets and/or software tools used].\n\nAbbreviations: N, number of patients in treatment arm; n, number of patients with given characteristic; SD, standard deviation\n\n\nNote that the prune_0 argument can be set to specify whether all-zero rows should be included in a table. For example, see that the demographics table below includes rows for OTHER and UNKNOWN for which all values are zero, whereas these two rows were excluded from the previous tables (prune_0 defaults to TRUE in make_table_02()).\n\nmake_table_02(df = anl, vars = \"RACE\", prune_0 = FALSE)\n\n                                              A: Drug X    B: Placebo   C: Combination   Total Population\nCharacteristic                                 (N=134)      (N=134)        (N=132)           (N=400)     \n—————————————————————————————————————————————————————————————————————————————————————————————————————————\nRace                                                                                                     \n  ASIAN                                       68 (50.7%)    67 (50%)      73 (55.3%)        208 (52%)    \n  BLACK OR AFRICAN AMERICAN                   31 (23.1%)   28 (20.9%)     32 (24.2%)        91 (22.8%)   \n  WHITE                                       27 (20.1%)   26 (19.4%)     21 (15.9%)        74 (18.5%)   \n  AMERICAN INDIAN OR ALASKA NATIVE              8 (6%)     11 (8.2%)       6 (4.5%)         25 (6.2%)    \n  MULTIPLE                                        0         1 (0.7%)          0              1 (0.2%)    \n  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER       0         1 (0.7%)          0              1 (0.2%)    \n  OTHER                                           0            0              0                 0        \n  UNKNOWN                                         0            0              0                 0        \n\n\nFeature Requests\nIf you would like to request the addition of a new feature to a pre-existing function within falcon, or would like a specific table template to be added, please file an issue on GitHub here or reach out to the falcon team directly via our Slack channel here.\nYou can access the source code for all currently available functions in the falcon GitHub repository here.\nAdditional Resources\nSee the following packages used by falcon for more information:\n\n\nrtables: Table creation\n\nrlistings: Listing creation\n\ntern: Clinical trials analysis functions\n\nformatters: Additional rendering formatting\n\n`random.cdisc.data``: Example synthetic randomized CDISC datasets (required for examples only)"
  },
  {
    "objectID": "quarto/resources.html",
    "href": "quarto/resources.html",
    "title": "Resources",
    "section": "",
    "text": "FDA Standard Safety Tables and Figures: Integrated Guide\nClick here to download.\n\n\n\nPast Talks & Presentations\n\nPHUSE EU Connect Presentation\n\nDate: November 6, 2023\nClick here to download the presentation slide deck.\n\n\n\nR/Pharma Online Workshop\n\nDate: October 20, 2023\nClick here to download the workshop slide deck."
  },
  {
    "objectID": "quarto/table-templates/template-table_13.html",
    "href": "quarto/table-templates/template-table_13.html",
    "title": "FDA Table 13",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                          A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\nDictionary-Derived Term    (N=134)      (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————————————\ndcd A.1.1.1.1             50 (37.3%)   45 (33.6%)     63 (47.7%)          -3.7 (-15.2 - 7.7)     \ndcd B.2.2.3.1             48 (35.8%)   54 (40.3%)     51 (38.6%)          4.5 (-7.1 - 16.1)      \ndcd C.2.1.2.1             35 (26.1%)   48 (35.8%)     55 (41.7%)          9.7 (-1.3 - 20.7)      \ndcd D.2.1.5.3             47 (35.1%)   58 (43.3%)     57 (43.2%)          8.2 (-3.4 - 19.9)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Select Preferred Term Variable\npref_var &lt;- \"AEDECOD\"\n\n# Select Minimum Frequency (%)\nmin_freq &lt;- 0.40\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_13(adae = adae, alt_counts_df = adsl, pref_var = pref_var, min_freq = min_freq, risk_diff = risk_diff)\n\n\n\nmake_table_13()\n\nRequired variables:\n\n\nadae: USUBJID and the variables specified by pref_var, arm_var, and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\nmin_freq\n(proportion) Minimum % frequency (fraction of N) required in any column to include each row.\n0.05\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable from adae to include in the table.\n\"AEDECOD\"\n\n\nlbl_pref_var\n(character) Label corresponding to preferred term variable pref_var to print in the table.\nformatters::var_labels(adae, fill = TRUE)[pref_var]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_16.html",
    "href": "quarto/table-templates/template-table_16.html",
    "title": "FDA Table 16",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nFMQ (Broad)            A: Drug X   B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  Preferred Term        (N=134)     (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————————\nErectile Dysfunction                                                                         \n  dcd B.2.2.3.1        11 (8.2%)   12 (9.0%)      14 (10.6%)           0.7 (-6.0 - 7.5)      \n  dcd C.1.1.1.3        7 (5.2%)     5 (3.7%)       7 (5.3%)           -1.5 (-6.4 - 3.5)      \nGynecomastia                                                                                 \n  dcd B.2.2.3.1        10 (7.5%)   16 (11.9%)     15 (11.4%)          4.5 (-2.6 - 11.5)      \n  dcd C.1.1.1.3        7 (5.2%)     6 (4.5%)      10 (7.6%)           -0.7 (-5.9 - 4.4)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables FMQ01SC and FMQ01NAM exist in adae\nset.seed(1)\nadae &lt;- dplyr::rename(adae, FMQ01SC = SMQ01SC, FMQ01NAM = SMQ01NAM)\nlevels(adae$FMQ01SC) &lt;- c(\"BROAD\", \"NARROW\")\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\nadae$FMQ01NAM &lt;- factor(adae$FMQ01NAM, levels = c(unique(adae$FMQ01NAM), \"Erectile Dysfunction\", \"Gynecomastia\"))\nadae$FMQ01NAM[adae$SEX == \"M\"] &lt;- as.factor(\n  sample(c(\"Erectile Dysfunction\", \"Gynecomastia\"), sum(adae$SEX == \"M\"), replace = TRUE)\n)\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\")\nmake_table_16(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_16()\n\nRequired variables:\n\n\nadae: adae must contain USUBJID, SEX, and the variables specified by arm_var, saffl_var, pref_var, fmqsc_var and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable to use in table.\n\"AEDECOD\"\n\n\nsex_scope\n(character) Level of SEX to output in table.\n\"M\"\n\n\nfmq_scope\n(character) FMQ scope value to use in table.\n\"BROAD\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_04.html",
    "href": "quarto/table-templates/template-table_04.html",
    "title": "FDA Table 4",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                          A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n                           (N=134)      (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————————————\nPatients randomized       63 (47.0%)   67 (50.0%)     67 (50.8%)          3.0 (-9.0 - 14.9)      \nITT/mITT population       134 (100%)   134 (100%)     132 (100%)           0.0 (0.0 - 0.0)       \nSafety population         134 (100%)   134 (100%)     132 (100%)           0.0 (0.0 - 0.0)       \nPer-protocol population   63 (47.0%)   67 (50.0%)     67 (50.8%)          3.0 (-9.0 - 14.9)      \nDiscontinued study drug   42 (31.3%)   40 (29.9%)     38 (28.8%)          -1.5 (-12.5 - 9.5)     \n  Adverse event            3 (2.2%)     6 (4.5%)       5 (3.8%)            2.2 (-2.1 - 6.5)      \n  Lack of efficacy         2 (1.5%)     2 (1.5%)       3 (2.3%)            0.0 (-2.9 - 2.9)      \n  Protocol deviation          0            0              0                0.0 (0.0 - 0.0)       \n  Death                   25 (18.7%)   23 (17.2%)     22 (16.7%)          -1.5 (-10.7 - 7.7)     \n  Withdrawal by subject       0            0              0                0.0 (0.0 - 0.0)       \n  Other                    3 (2.2%)     4 (3.0%)       3 (2.3%)            0.7 (-3.1 - 4.6)      \nDiscontinued study        42 (31.3%)   40 (29.9%)     38 (28.8%)          -1.5 (-12.5 - 9.5)     \n  Death                   25 (18.7%)   23 (17.2%)     22 (16.7%)          -1.5 (-10.7 - 7.7)     \n  Lost to follow-up           0            0              0                0.0 (0.0 - 0.0)       \n  Withdrawal by subject       0            0              0                0.0 (0.0 - 0.0)       \n  Physician decision          0            0              0                0.0 (0.0 - 0.0)       \n  Protocol deviation       5 (3.7%)     3 (2.2%)       4 (3.0%)           -1.5 (-5.6 - 2.6)      \n  Other                    3 (2.2%)     4 (3.0%)       3 (2.3%)            0.7 (-3.1 - 4.6)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\nlibrary(dplyr)\n\nadsl &lt;- random.cdisc.data::cadsl %&gt;%\n  mutate(test = rbinom(400, 1, 0.5)) %&gt;%\n  mutate(\n    RANDFL = ifelse(test == 0, \"N\", \"Y\"),\n    PPROTFL = ifelse(test == 0, \"N\", \"Y\"),\n    DCSREAS = if_else(DCSREAS %in% c(\n      \"ADVERSE EVENT\", \"LACK OF EFFICACY\", \"PROTOCOL VIOLATION\",\n      \"DEATH\", \"WITHDRAWAL BY PARENT/GUARDIAN\"\n    ), DCSREAS, \"OTHER\")\n  ) %&gt;%\n  mutate(DCTREAS = DCSREAS)\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\ntbl &lt;- make_table_04(\n  df = adsl, pop_vars = c(\"RANDFL\", \"ITTFL\", \"SAFFL\", \"PPROTFL\"),\n  lbl_pop_vars = c(\"Patients randomized\", \"ITT/mITT population\", \"Safety population\", \"Per-protocol population\"),\n  risk_diff = risk_diff\n)\ntbl\n\n\n\nmake_table_04()\n\nRequired variables: - df: USUBJID, EOTSTT, DCTREAS, EOSSTT, DCSREAS and the variables specified by arm_var and pop_var. - alt_counts_df (if specified): USUBJID, and the variable specified by arm_var and pop_var.\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\npop_vars\n(named list of character) List of Population variables to use in Table\nc(\"SAFFL\")\n\n\nlbl_pop_vars\n(named list of character) List of row labels for populations defined by pop_vars\n\nc(\"Safety population\")\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_17.html",
    "href": "quarto/table-templates/template-table_17.html",
    "title": "FDA Table 17",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nFMQ (Narrow)                   A: Drug X   B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  Preferred Term                (N=134)     (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————————————————\nAbnormal Uterine Bleeding                                                                            \n  dcd A.1.1.1.1                13 (9.7%)   10 (7.5%)      10 (7.6%)           -2.2 (-8.9 - 4.5)      \n  dcd A.1.1.1.2                10 (7.5%)    9 (6.7%)      14 (10.6%)          -0.7 (-6.9 - 5.4)      \n  dcd B.1.1.1.1                6 (4.5%)     7 (5.2%)       7 (5.3%)            0.7 (-4.4 - 5.9)      \n  dcd B.2.1.2.1                9 (6.7%)     8 (6.0%)       6 (4.5%)           -0.7 (-6.6 - 5.1)      \n  dcd C.2.1.2.1                7 (5.2%)     8 (6.0%)      11 (8.3%)            0.7 (-4.8 - 6.2)      \n  dcd D.1.1.1.1                3 (2.2%)    13 (9.7%)       9 (6.8%)            7.5 (1.9 - 13.1)      \n  dcd D.1.1.4.2                13 (9.7%)    8 (6.0%)       9 (6.8%)           -3.7 (-10.2 - 2.7)     \n  dcd D.2.1.5.3                9 (6.7%)    11 (8.2%)      11 (8.3%)            1.5 (-4.8 - 7.8)      \nAmenorrhea                                                                                           \n  dcd A.1.1.1.1                7 (5.2%)     8 (6.0%)      16 (12.1%)           0.7 (-4.8 - 6.2)      \n  dcd A.1.1.1.2                12 (9.0%)   14 (10.4%)      5 (3.8%)            1.5 (-5.6 - 8.6)      \n  dcd B.1.1.1.1                9 (6.7%)    14 (10.4%)      9 (6.8%)           3.7 (-3.0 - 10.4)      \n  dcd B.2.1.2.1                13 (9.7%)   10 (7.5%)       8 (6.1%)           -2.2 (-8.9 - 4.5)      \n  dcd C.2.1.2.1                6 (4.5%)     6 (4.5%)       9 (6.8%)            0.0 (-5.0 - 5.0)      \n  dcd D.1.1.1.1                11 (8.2%)    6 (4.5%)       8 (6.1%)           -3.7 (-9.6 - 2.1)      \n  dcd D.1.1.4.2                8 (6.0%)     3 (2.2%)       4 (3.0%)           -3.7 (-8.5 - 1.0)      \n  dcd D.2.1.5.3                7 (5.2%)    13 (9.7%)       9 (6.8%)           4.5 (-1.8 - 10.7)      \nBacterial Vaginosis                                                                                  \n  dcd A.1.1.1.1                8 (6.0%)     9 (6.7%)       5 (3.8%)            0.7 (-5.1 - 6.6)      \n  dcd A.1.1.1.2                6 (4.5%)     9 (6.7%)       8 (6.1%)            2.2 (-3.3 - 7.7)      \n  dcd B.1.1.1.1                10 (7.5%)    9 (6.7%)       6 (4.5%)           -0.7 (-6.9 - 5.4)      \n  dcd B.2.1.2.1                9 (6.7%)    10 (7.5%)       5 (3.8%)            0.7 (-5.4 - 6.9)      \n  dcd C.2.1.2.1                7 (5.2%)    12 (9.0%)       5 (3.8%)            3.7 (-2.4 - 9.9)      \n  dcd D.1.1.1.1                8 (6.0%)    11 (8.2%)       7 (5.3%)            2.2 (-3.9 - 8.4)      \n  dcd D.1.1.4.2                8 (6.0%)     7 (5.2%)      12 (9.1%)           -0.7 (-6.2 - 4.8)      \n  dcd D.2.1.5.3                7 (5.2%)    11 (8.2%)       9 (6.8%)            3.0 (-3.0 - 9.0)      \nDecreased Menstrual Bleeding                                                                         \n  dcd A.1.1.1.1                12 (9.0%)   13 (9.7%)       9 (6.8%)            0.7 (-6.2 - 7.7)      \n  dcd A.1.1.1.2                10 (7.5%)   11 (8.2%)       7 (5.3%)            0.7 (-5.7 - 7.2)      \n  dcd B.1.1.1.1                6 (4.5%)     6 (4.5%)       8 (6.1%)            0.0 (-5.0 - 5.0)      \n  dcd B.2.1.2.1                5 (3.7%)    12 (9.0%)       6 (4.5%)           5.2 (-0.6 - 11.0)      \n  dcd C.2.1.2.1                8 (6.0%)    13 (9.7%)       8 (6.1%)           3.7 (-2.7 - 10.2)      \n  dcd D.1.1.1.1                8 (6.0%)     6 (4.5%)      11 (8.3%)           -1.5 (-6.8 - 3.8)      \n  dcd D.1.1.4.2                9 (6.7%)     8 (6.0%)       8 (6.1%)           -0.7 (-6.6 - 5.1)      \n  dcd D.2.1.5.3                11 (8.2%)   12 (9.0%)      12 (9.1%)            0.7 (-6.0 - 7.5)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables FMQ01SC and FMQ01NAM exist in adae\nset.seed(1)\nadae &lt;- dplyr::rename(adae, FMQ01SC = SMQ01SC, FMQ01NAM = SMQ01NAM)\nlevels(adae$FMQ01SC) &lt;- c(\"BROAD\", \"NARROW\")\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\nadae$FMQ01NAM &lt;- factor(adae$FMQ01NAM, levels = c(\n  unique(adae$FMQ01NAM), \"Abnormal Uterine Bleeding\", \"Amenorrhea\",\n  \"Bacterial Vaginosis\", \"Decreased Menstrual Bleeding\"\n))\nadae$FMQ01NAM[adae$SEX == \"F\"] &lt;- as.factor(\n  sample(c(\n    \"Abnormal Uterine Bleeding\", \"Amenorrhea\",\n    \"Bacterial Vaginosis\", \"Decreased Menstrual Bleeding\"\n  ), sum(adae$SEX == \"F\"), replace = TRUE)\n)\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\")\nmake_table_17(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_17()\n\nRequired variables:\n\n\nadae: adae must contain USUBJID, SEX, and the variables specified by arm_var, saffl_var, pref_var, fmqsc_var and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable to use in table.\n\"AEDECOD\"\n\n\nsex_scope\n(character) Level of SEX to output in table.\n\"F\"\n\n\nfmq_scope\n(character) FMQ scope value to use in table.\n\"NARROW\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_35.html",
    "href": "quarto/table-templates/template-table_35.html",
    "title": "FDA Table 35",
    "section": "",
    "text": "Spec. Screenshot\nTable\nTable Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                             A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\nPrimary System Organ Class    (N=134)      (N=134)        (N=132)                 (N=268)           \n————————————————————————————————————————————————————————————————————————————————————————————————————\ncl D                         96 (71.6%)   90 (67.2%)     98 (74.2%)          -4.5 (-15.5 - 6.5)     \ncl B                         96 (71.6%)   89 (66.4%)     97 (73.5%)          -5.2 (-16.3 - 5.8)     \ncl A                         78 (58.2%)   75 (56.0%)     89 (67.4%)          -2.2 (-14.1 - 9.6)     \ncl C                         67 (50.0%)   75 (56.0%)     79 (59.8%)          6.0 (-6.0 - 17.9)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(random.cdisc.data)\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_35(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_35()\n\nRequired variables:\n\n\nadae: USUBJID and the variables specified by arm_var, saffl_var and soc_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nsoc_var\n(character) SOC variable from adae to include in the table.\n\"AEDECOD\"\n\n\nlbl_soc_var\n(character) Label corresponding to SOC variable soc_var to print in the table.\nformatters::var_labels(adae, fill = TRUE)[soc_var]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_09.html",
    "href": "quarto/table-templates/template-table_09.html",
    "title": "FDA Table 9",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\ngt Table\ngt Table Setup\nFunction Details: make_table_09_gtsum\n\n\n\n\n\n\n\n\n\n\n\nSystem Organ Class           A: Drug X    B: Placebo    C: Combination   Risk Difference (%) (95% CI)\n  Dictionary-Derived Term     (N=134)       (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————————————————\nAny SAE                     104 (77.6%)   101 (75.4%)     99 (75.0%)          -2.2 (-12.4 - 7.9)     \ncl A                        48 (35.8%)    48 (35.8%)      50 (37.9%)          0.0 (-11.5 - 11.5)     \n  dcd A.1.1.1.2             48 (35.8%)    48 (35.8%)      50 (37.9%)          0.0 (-11.5 - 11.5)     \ncl B                        79 (59.0%)    78 (58.2%)      76 (57.6%)         -0.7 (-12.5 - 11.0)     \n  dcd B.1.1.1.1             47 (35.1%)    49 (36.6%)      43 (32.6%)          1.5 (-10.0 - 13.0)     \n  dcd B.2.2.3.1             48 (35.8%)    54 (40.3%)      51 (38.6%)          4.5 (-7.1 - 16.1)      \ncl D                        50 (37.3%)    42 (31.3%)      51 (38.6%)          -6.0 (-17.3 - 5.4)     \n  dcd D.1.1.1.1             50 (37.3%)    42 (31.3%)      51 (38.6%)          -6.0 (-17.3 - 5.4)     \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Select Preferred Term Variable\npref_var &lt;- \"AEDECOD\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_09(adae = adae, alt_counts_df = adsl, pref_var = pref_var, risk_diff = risk_diff)\n\n\n\nmake_table_09()\n\nRequired variables:\n\n\nadae: USUBJID, AESER, AESOC, and the variables specified by pref_var, arm_var, and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable from adae to include in the table.\n\"AEDECOD\"\n\n\nlbl_pref_var\n(character) Label corresponding to preferred term variable pref_var to print in the table.\nformatters::var_labels(adae, fill = TRUE)[pref_var]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here.\n\n\n\n\n\n\n\n\n\n\nPrimary System Organ Class     Dictionary-Derived Term\n      A: Drug X(N=134)\n      B: Placebo(N=134)\n      C: Combination(N=132)\n    \n\n\nAny SAE\n104 (77.6%)\n101 (75.4%)\n99 (75.0%)\n\n\ncl A\n48 (35.8%)\n48 (35.8%)\n50 (37.9%)\n\n\ndcd A.1.1.1.2\n48 (35.8%)\n48 (35.8%)\n50 (37.9%)\n\n\ncl B\n79 (59.0%)\n78 (58.2%)\n76 (57.6%)\n\n\ndcd B.1.1.1.1\n47 (35.1%)\n49 (36.6%)\n43 (32.6%)\n\n\ndcd B.2.2.3.1\n48 (35.8%)\n54 (40.3%)\n51 (38.6%)\n\n\ncl D\n50 (37.3%)\n42 (31.3%)\n51 (38.6%)\n\n\ndcd D.1.1.1.1\n50 (37.3%)\n42 (31.3%)\n51 (38.6%)\n\n\n\n\n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Output Table\nmake_table_09_gtsum(adae = adae, alt_counts_df = adsl)\n\n\n\nmake_table_09_gtsum()\n\nRequired variables:\n\n\nadae: SAFFL, USUBJID, AESER, AESOC, and the variables specified by pref_var and arm_var.\n\nalt_counts_df (if specified): SAFFL, USUBJID, and the variable specified by arm_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Safety population flag variable from adae to include in the table.\n\"SAFFL\"\n\n\nser_var\n(character) Serious Event variable from adae to include in the table.\n\"AESER\"\n\n\npref_var\n(character) Preferred term variable from adae to include in the table.\n\"AEDECOD\"\n\n\nsoc_var\n(character) Preferred term variable from adae to include in the table.\n\"AESOC\"\n\n\nlbl_pref_var\n(character) Label corresponding to preferred term variable pref_var to print in the table.\nformatters::var_labels(adae, fill = TRUE)[pref_var]\n\n\nlbl_soc_var\n(character) Label corresponding to system organ class variable soc_var to print in the table.\nformatters::var_labels(adae, fill = TRUE)[soc_var]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, and a list of characters called footnotes. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\nrisk_diff\n(list of character vectors) List of character vectors. Each vector must be\n\n\n\n\nof length 2 and contain the name of treatment arms to calculate risk difference and its 95% CI for. Those names must exist in the arm_var column of the dataset specified in adae. | NULL |\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_08.html",
    "href": "quarto/table-templates/template-table_08.html",
    "title": "FDA Table 8",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                                             Dosing    Study           Cause of Death                              \n                                          Age/              Duration   Day of              MedDRA                 Cause of Death   \n  Study Arm           Patient ID         Gender   Dosage     (Days)    Death           Preferred Term              Verbatim Term   \n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\n  A: Drug X       AB12345-BRA-1-id-42     36/M    5040 mg      37        NA                  NA                         NA         \n                  AB12345-BRA-1-id-93     34/F    6720 mg      37       657             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-BRA-11-id-345    37/F    7680 mg      37        NA                  NA                         NA         \n                 AB12345-BRA-11-id-397    38/M    7680 mg      37        NA                  NA                         NA         \n                 AB12345-BRA-13-id-177    24/M    4800 mg      37        NA                  NA                         NA         \n                 AB12345-BRA-15-id-36     38/F    7200 mg      37       812          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-BRA-2-id-296     44/F    4800 mg      37        NA                  NA                         NA         \n                 AB12345-CAN-11-id-139    31/M    6000 mg      37       563             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-CHN-1-id-123     27/F    5280 mg      37       750          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-CHN-1-id-133     25/F    5520 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-235     39/M    5520 mg      37       968             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-CHN-1-id-275     27/M    7200 mg      38        NA                  NA                         NA         \n                 AB12345-CHN-1-id-277     41/M    8160 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-315     32/M    6480 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-316     25/F    8400 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-329     48/M    5520 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-47     25/F    5520 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-53     48/M    6960 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-69     32/F    6960 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-71     33/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-116    30/M    8880 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-124    41/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-132    30/F    6000 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-153    41/M    7680 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-167    28/F    4800 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-256    23/M    6720 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-354    42/F    5280 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-356    28/F    8160 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-392    39/M    5280 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-12-id-266    32/F    5520 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-12-id-396    25/F    8880 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-14-id-1     27/F    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-14-id-161    33/F    6480 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-14-id-168    39/M    6960 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-15-id-399    33/F    7200 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-17-id-182    37/M    7680 mg      37       902           LOST TO FOLLOW UP                OTHER       \n                 AB12345-CHN-17-id-309    36/F    7200 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-17-id-92     29/M    5520 mg      38       721           LOST TO FOLLOW UP                OTHER       \n                 AB12345-CHN-18-id-170    31/M    7200 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-2-id-22     29/M    8400 mg      38       409                MISSING                     OTHER       \n                 AB12345-CHN-2-id-223     29/F    5760 mg      37       468          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-CHN-2-id-272     41/F    4320 mg      37       773          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-CHN-2-id-274     40/F    5520 mg      37       890                SUICIDE                     OTHER       \n                 AB12345-CHN-2-id-284     36/F    7200 mg      38        NA                  NA                         NA         \n                 AB12345-CHN-2-id-286     30/F    8400 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-2-id-367     40/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-2-id-395     28/M    5520 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-3-id-271     24/F    4320 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-3-id-281     41/M    4560 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-4-id-335     33/F    6720 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-4-id-73     24/F    7920 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-5-id-108     28/F    7440 mg      37       935                MISSING                     OTHER       \n                 AB12345-CHN-5-id-273     34/F    6240 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-5-id-348     37/M    5520 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-6-id-30     29/M    5280 mg      37       578     Post-study reporting of death          OTHER       \n                 AB12345-CHN-8-id-205     34/F    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-9-id-374     31/F    6960 mg      37        NA                  NA                         NA         \n                 AB12345-GBR-1-id-319     36/F    8160 mg      37       531             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-JPN-18-id-189    48/M    7920 mg      37        NA                  NA                         NA         \n                 AB12345-JPN-5-id-326     34/F    7680 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-1-id-388     39/F    5760 mg      37        NA                  NA                         NA         \n                  AB12345-NGA-1-id-46     28/M    6480 mg      37       697          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-NGA-11-id-41     29/M    8160 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-2-id-353     28/M    6960 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-1-id-148     46/M    7440 mg      37        NA                  NA                         NA         \n                  AB12345-PAK-1-id-79     37/M    5040 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-11-id-187    32/F    6240 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-12-id-328    21/F    7680 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-13-id-251    32/M    7680 mg      37        NA                  NA                         NA         \n                  AB12345-RUS-1-id-52     40/F    6960 mg      37       1069         DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-RUS-13-id-70     39/F    6720 mg      37        NA                  NA                         NA         \n                  AB12345-RUS-6-id-77     26/F    5760 mg      37       495             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-USA-11-id-32     24/F    7200 mg      37        NA                  NA                         NA         \n                 AB12345-USA-11-id-339    39/F    5280 mg      37       878                UNKNOWN                     OTHER       \n                 AB12345-USA-3-id-282     38/M    4800 mg      37        NA                  NA                         NA         \n                 AB12345-USA-9-id-130     40/M    5520 mg      37        NA                  NA                         NA         \n  B: Placebo     AB12345-BRA-1-id-236     32/M    6480 mg      37        NA                  NA                         NA         \n                  AB12345-BRA-1-id-65     25/F    9120 mg      37        NA                  NA                         NA         \n                 AB12345-BRA-12-id-59     36/M    6480 mg      38        NA                  NA                         NA         \n                 AB12345-BRA-4-id-383     30/F    7680 mg      37        NA                  NA                         NA         \n                 AB12345-CAN-1-id-341     43/F    5520 mg      37       1013               SUICIDE                     OTHER       \n                 AB12345-CAN-4-id-331     34/F    6480 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-107     41/M    6240 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-156     32/F    6000 mg      37       542                SUICIDE                     OTHER       \n                 AB12345-CHN-1-id-186     27/M    5520 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-197     31/F    6960 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-212     30/F    5040 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-33     31/F    6960 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-346     21/M    7920 mg      37       834             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-CHN-1-id-400     26/F    6960 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-86     31/F    8640 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-97     39/F    4080 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-174    41/M    4320 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-220    26/F    4560 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-24     46/F    6720 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-247    30/M    4560 mg      38        NA                  NA                         NA         \n                 AB12345-CHN-11-id-278    47/F    6480 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-289    40/F    4800 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-291    50/M    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-317    38/F    6240 mg      37       658          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-CHN-11-id-318    42/F    7920 mg      37       910          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-CHN-11-id-358    32/F    4560 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-362    39/F    6240 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-364    48/F    4800 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-54     26/M    5040 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-90     37/F    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-12-id-294    35/F    8400 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-12-id-322    37/M    7920 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-13-id-102    37/M    5280 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-13-id-19     30/F    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-13-id-239    58/F    6720 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-13-id-304    29/F    5280 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-14-id-305    28/F    5760 mg      37       406     Post-study reporting of death          OTHER       \n                 AB12345-CHN-16-id-323    51/M    7680 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-17-id-48     32/F    6000 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-2-id-118     36/F    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-2-id-332     31/F    5760 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-2-id-34     48/M    5280 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-3-id-333     30/F    8160 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-4-id-122     23/M    8160 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-5-id-231     37/F    4800 mg      37       468             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-CHN-5-id-338     37/F    7920 mg      38        NA                  NA                         NA         \n                 AB12345-CHN-6-id-385     40/F    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-7-id-126     27/M    7920 mg      37       1066            ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-CHN-7-id-202     44/F    9120 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-7-id-267     40/M    5280 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-9-id-11     28/F    5280 mg      37       398                UNKNOWN                     OTHER       \n                 AB12345-CHN-9-id-147     26/F    6240 mg      37        NA                  NA                         NA         \n                 AB12345-GBR-17-id-211    62/M    5760 mg      37       455          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-GBR-6-id-111     30/F    5520 mg      37        NA                  NA                         NA         \n                  AB12345-JPN-1-id-21     29/F    7440 mg      38        NA                  NA                         NA         \n                 AB12345-JPN-14-id-194    28/F    5040 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-1-id-325     28/F    5760 mg      37       935          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-NGA-2-id-308     26/F    5520 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-1-id-112     44/M    4080 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-1-id-169     29/M    7680 mg      37        NA                  NA                         NA         \n                  AB12345-PAK-1-id-17     33/M    7680 mg      37        NA                  NA                         NA         \n                  AB12345-RUS-5-id-29     58/M    6960 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-138     36/M    8160 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-261     32/F    4080 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-269     35/F    8400 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-394     46/F    6960 mg      37        NA                  NA                         NA         \n                 AB12345-USA-11-id-157    50/M    6720 mg      37        NA                  NA                         NA         \n                 AB12345-USA-12-id-152    29/F    6240 mg      37        NA                  NA                         NA         \n                 AB12345-USA-12-id-226    30/M    5040 mg      37        NA                  NA                         NA         \n                 AB12345-USA-4-id-190     53/M    4560 mg      37        NA                  NA                         NA         \nC: Combination   AB12345-BRA-1-id-141     35/F    6960 mg      37        NA                  NA                         NA         \n                 AB12345-BRA-1-id-265     25/M    6000 mg      37       872                SUICIDE                     OTHER       \n                 AB12345-BRA-11-id-321    33/F    9360 mg      37        NA                  NA                         NA         \n                  AB12345-BRA-11-id-9     40/M    7200 mg      38       1091         DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-BRA-4-id-368     46/M    6720 mg      37        NA                  NA                         NA         \n                 AB12345-BRA-5-id-234     32/M    4800 mg      37        NA                  NA                         NA         \n                 AB12345-CAN-4-id-324     32/M    6240 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-181     47/F    5520 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-208     28/M    7680 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-233     36/F    7680 mg      37       406                MISSING                     OTHER       \n                 AB12345-CHN-1-id-279     33/M    7920 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-312     34/F    5280 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-347     33/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-1-id-376     41/F    5760 mg      38        NA                  NA                         NA         \n                  AB12345-CHN-1-id-64     34/F    6960 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-74     23/F    8400 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-1-id-78     44/F    8160 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-113    38/M    6960 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-146    28/F    5040 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-158    24/F    7200 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-184    38/F    8400 mg      37       1029         DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                 AB12345-CHN-11-id-192    35/F    8640 mg      37       807          DISEASE PROGRESSION        PROGRESSIVE DISEASE\n                  AB12345-CHN-11-id-2     37/F    8880 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-298    31/M    6720 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-11-id-63     30/M    6720 mg      38        NA                  NA                         NA         \n                 AB12345-CHN-14-id-143    36/F    6720 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-14-id-375    32/F    8400 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-14-id-56     25/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-15-id-262    35/M    7680 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-15-id-297    31/M    8880 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-16-id-352    28/M    6480 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-16-id-381    45/M    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-17-id-31     35/F    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-17-id-84     40/F    4560 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-18-id-106    30/F    5040 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-2-id-292     32/F    6960 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-2-id-342     32/M    6000 mg      38        NA                  NA                         NA         \n                  AB12345-CHN-2-id-98     48/M    8400 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-3-id-155     35/F    6000 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-3-id-259     27/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-4-id-115     38/M    5760 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-5-id-221     40/F    6720 mg      37        NA                  NA                         NA         \n                  AB12345-CHN-5-id-83     44/M    6960 mg      37        NA                  NA                         NA         \n                 AB12345-CHN-7-id-290     33/M    6000 mg      37        NA                  NA                         NA         \n                 AB12345-GBR-11-id-390    69/M    6000 mg      37        NA                  NA                         NA         \n                  AB12345-JPN-1-id-7      54/F    8880 mg      37        NA                  NA                         NA         \n                 AB12345-JPN-11-id-135    37/F    5760 mg      37        NA                  NA                         NA         \n                 AB12345-JPN-11-id-373    45/M    7440 mg      37        NA                  NA                         NA         \n                 AB12345-JPN-12-id-219    37/F    5520 mg      37        NA                  NA                         NA         \n                 AB12345-JPN-17-id-393    26/M    7920 mg      38       652             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-JPN-5-id-252     31/F    4800 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-1-id-198     32/F    7680 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-1-id-357     41/M    5040 mg      37        NA                  NA                         NA         \n                  AB12345-NGA-1-id-43     37/M    6720 mg      37        NA                  NA                         NA         \n                  AB12345-NGA-1-id-96     28/M    5760 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-11-id-173    24/F    6000 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-11-id-334    20/M    5280 mg      37        NA                  NA                         NA         \n                 AB12345-NGA-11-id-35     32/M    7440 mg      37       923             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-NGA-4-id-215     40/F    8880 mg      37       647             ADVERSE EVENT              ADVERSE EVENT   \n                 AB12345-PAK-1-id-125     49/F    7200 mg      37        NA                  NA                         NA         \n                  AB12345-PAK-1-id-95     28/F    6240 mg      37       1027    Post-study reporting of death          OTHER       \n                 AB12345-PAK-2-id-188     23/F    7200 mg      37        NA                  NA                         NA         \n                 AB12345-PAK-2-id-191     38/F    5520 mg      37        NA                  NA                         NA         \n                  AB12345-PAK-5-id-20     40/M    6960 mg      37        NA                  NA                         NA         \n                 AB12345-RUS-3-id-378     30/F    7440 mg      37        NA                  NA                         NA         \n                  AB12345-RUS-4-id-6      44/F    4320 mg      37        NA                  NA                         NA         \n                 AB12345-RUS-7-id-243     27/F    8400 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-137     29/M    5040 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-242     30/F    5760 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-254     28/F    5520 mg      37        NA                  NA                         NA         \n                 AB12345-USA-1-id-295     30/F    5280 mg      38        NA                  NA                         NA         \n                 AB12345-USA-12-id-140    32/F    7680 mg      37        NA                  NA                         NA         \n                 AB12345-USA-19-id-58     47/M    5520 mg      37        NA                  NA                         NA         \n                 AB12345-USA-2-id-110     35/F    7920 mg      37        NA                  NA                         NA         \n                 AB12345-USA-8-id-206     34/F    6240 mg      37        NA                  NA                         NA         \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadae &lt;- random.cdisc.data::cadae\nadex &lt;- random.cdisc.data::cadex\n\n# Output Table\nmake_table_08(adae = adae, adex = adex)\n\n\n\nmake_table_08()\n\nRequired variables:\n\n\nadae: USUBJID, AGE, SEX, AESDTH, DTHADY, and the variables specified by dth_vars, arm_var, and saffl_var.\n\nadex (if specified): USUBJID, PARAMCD, TRTSDT, TRTEDT, AVAL, AVALU, and the variable specified by saffl_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nadex\n(data.frame) Dataset (typically ADEX) required to build table.\nNo default\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\ndth_var\n(vector of character) additional death variables from adae to include in the table.\nc(\"DTHCAUS\", \"DTHCAT\")\n\n\nlbl_dth_vars\n(vector of character) labels corresponding to variables in dth_vars to print in the table. Labels should be ordered according to the order of variables in dth_vars.\nc(\"Cause of Death\\nMedDRA\\nPreferred Term\", \"Cause of Death\\nVerbatim Term\")\n\n\nna_level\n(character) String to represent missing values.\n\"NA\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_20.html",
    "href": "quarto/table-templates/template-table_20.html",
    "title": "FDA Table 20",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                A: Drug X    B: Placebo    C: Combination   Risk Difference (%) (95% CI)\nAESI Assessment                  (N=134)       (N=134)        (N=132)                 (N=268)           \n————————————————————————————————————————————————————————————————————————————————————————————————————————\nAE grouping related to AESI    107 (79.9%)   112 (83.6%)    113 (85.6%)          3.7 (-5.5 - 13.0)      \n  dcd A.1.1.1.1                50 (37.3%)    45 (33.6%)      63 (47.7%)          -3.7 (-15.2 - 7.7)     \n  dcd A.1.1.1.2                48 (35.8%)    48 (35.8%)      50 (37.9%)          0.0 (-11.5 - 11.5)     \n  dcd D.1.1.1.1                50 (37.3%)    42 (31.3%)      51 (38.6%)          -6.0 (-17.3 - 5.4)     \n  dcd D.1.1.4.2                48 (35.8%)    42 (31.3%)      50 (37.9%)          -4.5 (-15.8 - 6.8)     \n  dcd D.2.1.5.3                47 (35.1%)    58 (43.3%)      57 (43.2%)          8.2 (-3.4 - 19.9)      \nMaximum severity                                                                                        \n  MILD                         16 (11.9%)    19 (14.2%)      17 (12.9%)          2.2 (-5.8 - 10.3)      \n  MODERATE                     41 (30.6%)    51 (38.1%)      45 (34.1%)          7.5 (-3.9 - 18.8)      \n  SEVERE                       50 (37.3%)    42 (31.3%)      51 (38.6%)          -6.0 (-17.3 - 5.4)     \nSerious                        75 (56.0%)    77 (57.5%)      83 (62.9%)          1.5 (-10.4 - 13.4)     \n  Deaths                       50 (37.3%)    42 (31.3%)      51 (38.6%)          -6.0 (-17.3 - 5.4)     \nResulting in discontinuation   35 (26.1%)    34 (25.4%)      33 (25.0%)          -0.7 (-11.2 - 9.7)     \nRelatedness                    74 (55.2%)    74 (55.2%)      84 (63.6%)          0.0 (-11.9 - 11.9)     \nLaboratory Assessment          89 (66.4%)    86 (64.2%)      90 (68.2%)          -2.2 (-13.6 - 9.2)     \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Add/create any required variables in adae\nset.seed(1)\nadae$AESIFL &lt;- ifelse(adae$AESOC %in% c(\"cl A\", \"cl D\"), \"Y\", \"N\")\nadae$AELABFL &lt;- sample(c(\"Y\", \"N\"), nrow(adae), replace = TRUE)\n\n# Select Preferred Term Variable\npref_var &lt;- \"AEDECOD\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_20(\n  adae = adae, alt_counts_df = adsl, pref_var = pref_var, aesifl_var = \"AESIFL\",\n  aelabfl_var = \"AELABFL\", risk_diff = risk_diff\n)\n\n\n\nmake_table_20()\n\nRequired variables:\n\n\nadae: USUBJID, AESEV, AESER, AESDTH, EOSSTT, AEREL, and the variables specified by pref_var, aesifl_var, aelabfl_var, arm_var, and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable from adae to include in the table.\n\"AEDECOD\"\n\n\naesifl_var\n(character) Variable from adae that indicates adverse events of special interest.\n\"AESIFL\"\n\n\naelabfl_var\n(character) Variable from adae that indicates a laboratory assessment.\n\"AELABFL\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_10.html",
    "href": "quarto/table-templates/template-table_10.html",
    "title": "FDA Table 10",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nBody System or Organ Class   A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  FMQ (Narrow)                (N=134)      (N=134)        (N=132)                 (N=268)           \n————————————————————————————————————————————————————————————————————————————————————————————————————\ncl A.1                                                                                              \n  FMQ1                       17 (12.7%)   14 (10.4%)     29 (22.0%)          -2.2 (-9.9 - 5.4)      \n  FMQ2                       23 (17.2%)   20 (14.9%)     20 (15.2%)          -2.2 (-11.0 - 6.5)     \n  FMQ3                       20 (14.9%)   19 (14.2%)     23 (17.4%)          -0.7 (-9.2 - 7.7)      \ncl B.1                                                                                              \n  FMQ1                        8 (6.0%)    11 (8.2%)       7 (5.3%)            2.2 (-3.9 - 8.4)      \n  FMQ2                        5 (3.7%)    12 (9.0%)      16 (12.1%)          5.2 (-0.6 - 11.0)      \n  FMQ3                       10 (7.5%)     7 (5.2%)       5 (3.8%)           -2.2 (-8.1 - 3.6)      \ncl B.2                                                                                              \n  FMQ1                       13 (9.7%)    15 (11.2%)      9 (6.8%)            1.5 (-5.8 - 8.8)      \n  FMQ2                       12 (9.0%)     9 (6.7%)      10 (7.6%)           -2.2 (-8.7 - 4.2)      \n  FMQ3                        6 (4.5%)     7 (5.2%)       9 (6.8%)            0.7 (-4.4 - 5.9)      \ncl C.2                                                                                              \n  FMQ1                        9 (6.7%)     9 (6.7%)      12 (9.1%)            0.0 (-6.0 - 6.0)      \n  FMQ2                        6 (4.5%)     8 (6.0%)       8 (6.1%)            1.5 (-3.8 - 6.8)      \n  FMQ3                        6 (4.5%)     9 (6.7%)      10 (7.6%)            2.2 (-3.3 - 7.7)      \ncl D.1                                                                                              \n  FMQ1                       23 (17.2%)   17 (12.7%)     27 (20.5%)          -4.5 (-13.0 - 4.0)     \n  FMQ2                       22 (16.4%)   20 (14.9%)     25 (18.9%)          -1.5 (-10.2 - 7.2)     \n  FMQ3                       15 (11.2%)   19 (14.2%)     21 (15.9%)          3.0 (-5.0 - 10.9)      \ncl D.2                                                                                              \n  FMQ1                        8 (6.0%)    11 (8.2%)       9 (6.8%)            2.2 (-3.9 - 8.4)      \n  FMQ2                       14 (10.4%)   15 (11.2%)     14 (10.6%)           0.7 (-6.7 - 8.2)      \n  FMQ3                       11 (8.2%)     9 (6.7%)      11 (8.3%)           -1.5 (-7.8 - 4.8)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(dplyr)\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables fmqsc_var and fmqnam_var exist in adae\nset.seed(1)\nadae &lt;- adae %&gt;%\n  rename(FMQ01SC = SMQ01SC) %&gt;%\n  mutate(\n    AESER = sample(c(\"Y\", \"N\"), size = nrow(adae), replace = TRUE),\n    FMQ01NAM = sample(c(\"FMQ1\", \"FMQ2\", \"FMQ3\"), size = nrow(adae), replace = TRUE)\n  )\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_10(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_10()\n\nRequired variables:\n\n\nadae: USUBJID, AEBODSYS, AESER, and the variables specified by arm_var, saffl_var, fmqsc_var, and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nfmq_scope\n(character) FMQ scope, can be ‘“NARROW”’ or ‘“BROAD”’.\n\"NARROW\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_05.html",
    "href": "quarto/table-templates/template-table_05.html",
    "title": "FDA Table 5",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                           A: Drug X                    B: Placebo                 C: Combination         Risk Difference (%) (95% CI)\nParameter                                   (N=134)                      (N=134)                      (N=132)                       (N=268)           \n——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nDuration of Treatment, days                                                                                                                           \n  Mean (SD)                             961.49 (208.62)              949.45 (223.73)              984.71 (200.08)                      NA             \n  Median (min - max)               1095.75 (392.79 - 1095.75)   1095.75 (387.34 - 1095.75)   1095.75 (368.91 - 1095.75)                NA             \n  Interquartile range                   859.95 - 1095.75             781.56 - 1095.75             960.34 - 1095.75                     NA             \n  Total exposure (person years)        105763.56 (289.56)           100641.30 (275.54)           109302.29 (299.25)                    NA             \nPatients Treated, by duration                                                                                                                         \n  Any duration (at least 1 dose)          110 (82.1%)                  106 (79.1%)                  111 (84.1%)                -3.0 (-12.4 - 6.5)     \n  &lt;1 month                                     0                            0                            0                      0.0 (0.0 - 0.0)       \n  &gt;=1 month                               110 (82.1%)                  106 (79.1%)                  111 (84.1%)                -3.0 (-12.4 - 6.5)     \n  &gt;=3 months                              110 (82.1%)                  106 (79.1%)                  111 (84.1%)                -3.0 (-12.4 - 6.5)     \n  &gt;=6 months                              110 (82.1%)                  106 (79.1%)                  111 (84.1%)                -3.0 (-12.4 - 6.5)     \n  &gt;=12 months                             110 (82.1%)                  106 (79.1%)                  111 (84.1%)                -3.0 (-12.4 - 6.5)     \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_05(df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_05()\n\nRequired variables:\n\n\ndf: The variables specified by vars, arm_var, and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nid_var\n(character) Identifier variable used to count the participants within each flag.\n\"USUBJID\"\n\n\ntrtsdtm_var\n(character) Treatment start datetime variable in df.\n\"TRTSDTM\"\n\n\ntrtedtm_var\n(character) Treatment end datetime variable in df.\n\"TRTEDTM\"\n\n\nu_trtdur\n(character) Unit for duration of treatment. Options are \"days\", \"weeks\", \"months\" and \"years\".\n\"days\"\n\n\nlbl_trtdur\n(character) Label for treatment duration variable u_trtdur.\npaste(\"Duration of Treatment,\", u_trtdur)\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_34.html",
    "href": "quarto/table-templates/template-table_34.html",
    "title": "FDA Table 34",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nBody System or Organ Class   A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  FMQ (Narrow)                (N=134)      (N=134)        (N=132)                 (N=268)           \n————————————————————————————————————————————————————————————————————————————————————————————————————\ncl A.1                                                                                              \n  FMQ1                                                                                              \n    dcd A.1.1.1.1             7 (5.2%)     6 (4.5%)      13 (9.8%)           -0.7 (-5.9 - 4.4)      \n    dcd A.1.1.1.2            12 (9.0%)     8 (6.0%)      18 (13.6%)          -3.0 (-9.3 - 3.3)      \n  FMQ2                                                                                              \n    dcd A.1.1.1.1            13 (9.7%)    10 (7.5%)      12 (9.1%)           -2.2 (-8.9 - 4.5)      \n    dcd A.1.1.1.2            12 (9.0%)    10 (7.5%)       8 (6.1%)           -1.5 (-8.1 - 5.1)      \n  FMQ3                                                                                              \n    dcd A.1.1.1.1             8 (6.0%)     8 (6.0%)      13 (9.8%)            0.0 (-5.7 - 5.7)      \n    dcd A.1.1.1.2            13 (9.7%)    11 (8.2%)      11 (8.3%)           -1.5 (-8.3 - 5.3)      \ncl B.1                                                                                              \n  FMQ1                                                                                              \n    dcd B.1.1.1.1             8 (6.0%)    11 (8.2%)       7 (5.3%)            2.2 (-3.9 - 8.4)      \n  FMQ2                                                                                              \n    dcd B.1.1.1.1             5 (3.7%)    12 (9.0%)      16 (12.1%)          5.2 (-0.6 - 11.0)      \n  FMQ3                                                                                              \n    dcd B.1.1.1.1            10 (7.5%)     7 (5.2%)       5 (3.8%)           -2.2 (-8.1 - 3.6)      \ncl B.2                                                                                              \n  FMQ1                                                                                              \n    dcd B.2.1.2.1            13 (9.7%)    15 (11.2%)      9 (6.8%)            1.5 (-5.8 - 8.8)      \n  FMQ2                                                                                              \n    dcd B.2.1.2.1            12 (9.0%)     9 (6.7%)      10 (7.6%)           -2.2 (-8.7 - 4.2)      \n  FMQ3                                                                                              \n    dcd B.2.1.2.1             6 (4.5%)     7 (5.2%)       9 (6.8%)            0.7 (-4.4 - 5.9)      \ncl C.2                                                                                              \n  FMQ1                                                                                              \n    dcd C.2.1.2.1             9 (6.7%)     9 (6.7%)      12 (9.1%)            0.0 (-6.0 - 6.0)      \n  FMQ2                                                                                              \n    dcd C.2.1.2.1             6 (4.5%)     8 (6.0%)       8 (6.1%)            1.5 (-3.8 - 6.8)      \n  FMQ3                                                                                              \n    dcd C.2.1.2.1             6 (4.5%)     9 (6.7%)      10 (7.6%)            2.2 (-3.3 - 7.7)      \ncl D.1                                                                                              \n  FMQ1                                                                                              \n    dcd D.1.1.1.1             9 (6.7%)     9 (6.7%)      12 (9.1%)            0.0 (-6.0 - 6.0)      \n    dcd D.1.1.4.2            14 (10.4%)   10 (7.5%)      16 (12.1%)          -3.0 (-9.8 - 3.8)      \n  FMQ2                                                                                              \n    dcd D.1.1.1.1            15 (11.2%)   10 (7.5%)      16 (12.1%)          -3.7 (-10.7 - 3.2)     \n    dcd D.1.1.4.2            10 (7.5%)    10 (7.5%)      10 (7.6%)            0.0 (-6.3 - 6.3)      \n  FMQ3                                                                                              \n    dcd D.1.1.1.1             9 (6.7%)    10 (7.5%)      12 (9.1%)            0.7 (-5.4 - 6.9)      \n    dcd D.1.1.4.2             6 (4.5%)    11 (8.2%)       9 (6.8%)            3.7 (-2.1 - 9.6)      \ncl D.2                                                                                              \n  FMQ1                                                                                              \n    dcd D.2.1.5.3             8 (6.0%)    11 (8.2%)       9 (6.8%)            2.2 (-3.9 - 8.4)      \n  FMQ2                                                                                              \n    dcd D.2.1.5.3            14 (10.4%)   15 (11.2%)     14 (10.6%)           0.7 (-6.7 - 8.2)      \n  FMQ3                                                                                              \n    dcd D.2.1.5.3            11 (8.2%)     9 (6.7%)      11 (8.3%)           -1.5 (-7.8 - 4.8)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(dplyr)\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables fmqsc_var and fmqnam_var exist in adae\nset.seed(1)\nadae &lt;- adae %&gt;%\n  rename(FMQ01SC = SMQ01SC) %&gt;%\n  mutate(\n    AESER = sample(c(\"Y\", \"N\"), size = nrow(adae), replace = TRUE),\n    FMQ01NAM = sample(c(\"FMQ1\", \"FMQ2\", \"FMQ3\"), size = nrow(adae), replace = TRUE)\n  )\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\n\n# Select Preferred Term Variable\npref_var &lt;- \"AEDECOD\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_34(adae = adae, alt_counts_df = adsl, pref_var = pref_var, risk_diff = risk_diff)\n\n\n\nmake_table_34()\n\nRequired variables:\n\n\nadae: USUBJID, AEBODSYS, AESER, and the variables specified by arm_var, saffl_var, fmqsc_var, and fmqnam_var, and pref_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nfmq_scope\n(character) FMQ scope, can be ‘“NARROW”’ or ‘“BROAD”’.\n\"NARROW\"\n\n\npref_var\n(character) Preferred term variable from adae to include in the table.\n\"AEDECOD\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_06.html",
    "href": "quarto/table-templates/template-table_06.html",
    "title": "FDA Table 6",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                                                       A: Drug X    B: Placebo    C: Combination   Risk Difference (%) (95% CI)\nEvent                                                                   (N=134)       (N=134)        (N=132)                 (N=268)           \n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nSAE                                                                   104 (77.6%)   101 (75.4%)     99 (75.0%)          -2.2 (-12.4 - 7.9)     \n  SAEs with fatal outcome                                             76 (56.7%)    70 (52.2%)      75 (56.8%)          -4.5 (-16.4 - 7.4)     \n  Life-threatening SAEs                                                9 (6.7%)      13 (9.7%)      19 (14.4%)           3.0 (-3.6 - 9.5)      \n  SAEs requiring hospitalization                                      24 (17.9%)    28 (20.9%)      30 (22.7%)          3.0 (-6.5 - 12.4)      \n  SAEs resulting in substantial disruption of normal life functions   28 (20.9%)    21 (15.7%)      23 (17.4%)          -5.2 (-14.5 - 4.0)     \n  Congenital anomaly or birth defect                                  26 (19.4%)    27 (20.1%)      20 (15.2%)          0.7 (-8.8 - 10.3)      \n  Other                                                               30 (22.4%)    37 (27.6%)      32 (24.2%)          5.2 (-5.1 - 15.6)      \nAE leading to permanent discontinuation of study drug                 27 (20.1%)    26 (19.4%)      30 (22.7%)          -0.7 (-10.3 - 8.8)     \nAE leading to dose modification of study drug                         71 (53.0%)    86 (64.2%)      83 (62.9%)          11.2 (-0.5 - 22.9)     \n  AE leading to interruption of study drug                             4 (3.0%)      4 (3.0%)        3 (2.3%)            0.0 (-4.1 - 4.1)      \n  AE leading to reduction of study drug                               46 (34.3%)    46 (34.3%)      51 (38.6%)          0.0 (-11.4 - 11.4)     \n  AE leading to dose delay of study drug                              20 (14.9%)    28 (20.9%)      30 (22.7%)          6.0 (-3.2 - 15.1)      \n  Other                                                               34 (25.4%)    48 (35.8%)      46 (34.8%)          10.4 (-0.5 - 21.4)     \nAny AE                                                                122 (91.0%)   123 (91.8%)    120 (90.9%)           0.7 (-6.0 - 7.5)      \n  MILD                                                                 7 (5.2%)      9 (6.7%)        4 (3.0%)            1.5 (-4.2 - 7.2)      \n  MODERATE                                                            24 (17.9%)    24 (17.9%)      23 (17.4%)           0.0 (-9.2 - 9.2)      \n  SEVERE                                                              91 (67.9%)    90 (67.2%)      93 (70.5%)         -0.7 (-12.0 - 10.5)     \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_06(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_06()\n\nRequired variables:\n\n\nadae: USUBJID, TRTEMFL, AESEV, AESER, AESDTH, AESLIFE, AESHOSP, AESDISAB, AESCONG, AESMIE, AEACN, and the variables specified by arm_var and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_11.html",
    "href": "quarto/table-templates/template-table_11.html",
    "title": "FDA Table 11",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nBody System or Organ Class                                 A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  FMQ (Narrow)                                              (N=134)      (N=134)        (N=132)                 (N=268)           \n——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nPatients with at least one AE leading to discontinuation   83 (61.9%)   90 (67.2%)     88 (66.7%)          5.2 (-6.2 - 16.7)      \ncl A.1                                                     53 (39.6%)   55 (41.0%)     69 (52.3%)          1.5 (-10.3 - 13.2)     \n  FMQ1                                                     22 (16.4%)   21 (15.7%)     37 (28.0%)          -0.7 (-9.5 - 8.0)      \n  FMQ2                                                     24 (17.9%)   31 (23.1%)     33 (25.0%)          5.2 (-4.4 - 14.9)      \n  FMQ3                                                     28 (20.9%)   25 (18.7%)     31 (23.5%)          -2.2 (-11.8 - 7.3)     \ncl B.1                                                     35 (26.1%)   41 (30.6%)     36 (27.3%)          4.5 (-6.3 - 15.3)      \n  FMQ1                                                     12 (9.0%)    17 (12.7%)     19 (14.4%)          3.7 (-3.7 - 11.2)      \n  FMQ2                                                      9 (6.7%)    21 (15.7%)     20 (15.2%)           9.0 (1.5 - 16.4)      \n  FMQ3                                                     19 (14.2%)   11 (8.2%)       7 (5.3%)           -6.0 (-13.5 - 1.5)     \ncl B.2                                                     36 (26.9%)   33 (24.6%)     35 (26.5%)          -2.2 (-12.7 - 8.2)     \n  FMQ1                                                     16 (11.9%)   15 (11.2%)     12 (9.1%)           -0.7 (-8.4 - 6.9)      \n  FMQ2                                                     17 (12.7%)   12 (9.0%)      16 (12.1%)          -3.7 (-11.2 - 3.7)     \n  FMQ3                                                     11 (8.2%)    13 (9.7%)      15 (11.4%)           1.5 (-5.3 - 8.3)      \ncl C.2                                                     26 (19.4%)   39 (29.1%)     43 (32.6%)          9.7 (-0.5 - 19.9)      \n  FMQ1                                                     11 (8.2%)    12 (9.0%)      19 (14.4%)           0.7 (-6.0 - 7.5)      \n  FMQ2                                                     11 (8.2%)    15 (11.2%)     14 (10.6%)          3.0 (-4.1 - 10.1)      \n  FMQ3                                                      8 (6.0%)    14 (10.4%)     14 (10.6%)          4.5 (-2.1 - 11.0)      \ncl D.1                                                     51 (38.1%)   51 (38.1%)     60 (45.5%)          0.0 (-11.6 - 11.6)     \n  FMQ1                                                     22 (16.4%)   22 (16.4%)     32 (24.2%)           0.0 (-8.9 - 8.9)      \n  FMQ2                                                     24 (17.9%)   25 (18.7%)     33 (25.0%)          0.7 (-8.5 - 10.0)      \n  FMQ3                                                     19 (14.2%)   24 (17.9%)     26 (19.7%)          3.7 (-5.0 - 12.5)      \ncl D.2                                                     35 (26.1%)   46 (34.3%)     44 (33.3%)          8.2 (-2.7 - 19.2)      \n  FMQ1                                                     11 (8.2%)    23 (17.2%)     17 (12.9%)           9.0 (1.1 - 16.9)      \n  FMQ2                                                     18 (13.4%)   16 (11.9%)     18 (13.6%)          -1.5 (-9.5 - 6.5)      \n  FMQ3                                                     11 (8.2%)    16 (11.9%)     15 (11.4%)          3.7 (-3.5 - 10.9)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(dplyr)\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables fmqsc_var and fmqnam_var exist in adae\nset.seed(1)\nadae &lt;- adae %&gt;%\n  rename(FMQ01SC = SMQ01SC) %&gt;%\n  mutate(\n    AESER = sample(c(\"Y\", \"N\"), size = nrow(adae), replace = TRUE),\n    FMQ01NAM = sample(c(\"FMQ1\", \"FMQ2\", \"FMQ3\"), size = nrow(adae), replace = TRUE)\n  )\nadae$DCSREAS[is.na(adae$DCSREAS)] &lt;- \"ADVERSE EVENT\"\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_11(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_11()\n\nRequired variables:\n\n\nadae: USUBJID, AEBODSYS, AESER, DCSREAS, and the variables specified by arm_var, saffl_var, fmqsc_var, and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nfmq_scope\n(character) FMQ scope, can be ‘“NARROW”’ or ‘“BROAD”’.\n\"NARROW\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_15.html",
    "href": "quarto/table-templates/template-table_15.html",
    "title": "FDA Table 15",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nFMQ (Narrow)           A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  Preferred Term        (N=134)      (N=134)        (N=132)                 (N=268)           \n——————————————————————————————————————————————————————————————————————————————————————————————\nErectile Dysfunction                                                                          \n  dcd A.1.1.1.1        13 (9.7%)     9 (6.7%)      19 (14.4%)          -3.0 (-9.5 - 3.6)      \n  dcd A.1.1.1.2         9 (6.7%)     9 (6.7%)      13 (9.8%)            0.0 (-6.0 - 6.0)      \n  dcd B.1.1.1.1        10 (7.5%)    11 (8.2%)      14 (10.6%)           0.7 (-5.7 - 7.2)      \n  dcd B.2.1.2.1        11 (8.2%)    11 (8.2%)      18 (13.6%)           0.0 (-6.6 - 6.6)      \n  dcd C.2.1.2.1         7 (5.2%)     3 (2.2%)      13 (9.8%)           -3.0 (-7.5 - 1.5)      \n  dcd D.1.1.1.1        19 (14.2%)    6 (4.5%)      16 (12.1%)         -9.7 (-16.6 - -2.8)     \n  dcd D.1.1.4.2        11 (8.2%)     5 (3.7%)      14 (10.6%)          -4.5 (-10.1 - 1.2)     \n  dcd D.2.1.5.3        13 (9.7%)     9 (6.7%)      12 (9.1%)           -3.0 (-9.5 - 3.6)      \nGynecomastia                                                                                  \n  dcd A.1.1.1.1         6 (4.5%)     8 (6.0%)      18 (13.6%)           1.5 (-3.8 - 6.8)      \n  dcd A.1.1.1.2        10 (7.5%)     6 (4.5%)      15 (11.4%)          -3.0 (-8.6 - 2.7)      \n  dcd B.1.1.1.1        11 (8.2%)     8 (6.0%)      11 (8.3%)           -2.2 (-8.4 - 3.9)      \n  dcd B.2.1.2.1        11 (8.2%)     7 (5.2%)      19 (14.4%)          -3.0 (-9.0 - 3.0)      \n  dcd C.2.1.2.1         5 (3.7%)     9 (6.7%)      17 (12.9%)           3.0 (-2.3 - 8.3)      \n  dcd D.1.1.1.1         9 (6.7%)     7 (5.2%)      10 (7.6%)           -1.5 (-7.2 - 4.2)      \n  dcd D.1.1.4.2        11 (8.2%)    16 (11.9%)     12 (9.1%)           3.7 (-3.5 - 10.9)      \n  dcd D.2.1.5.3         9 (6.7%)    12 (9.0%)      14 (10.6%)           2.2 (-4.2 - 8.7)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables FMQ01SC and FMQ01NAM exist in adae\nset.seed(1)\nadae &lt;- dplyr::rename(adae, FMQ01SC = SMQ01SC, FMQ01NAM = SMQ01NAM)\nlevels(adae$FMQ01SC) &lt;- c(\"BROAD\", \"NARROW\")\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\nadae$FMQ01NAM &lt;- factor(adae$FMQ01NAM, levels = c(unique(adae$FMQ01NAM), \"Erectile Dysfunction\", \"Gynecomastia\"))\nadae$FMQ01NAM[adae$SEX == \"M\"] &lt;- as.factor(\n  sample(c(\"Erectile Dysfunction\", \"Gynecomastia\"), sum(adae$SEX == \"M\"), replace = TRUE)\n)\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\")\nmake_table_15(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_15()\n\nRequired variables:\n\n\nadae: adae must contain USUBJID, SEX, and the variables specified by arm_var, saffl_var, pref_var, fmqsc_var and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable to use in table.\n\"AEDECOD\"\n\n\nsex_scope\n(character) Level of SEX to output in table.\n\"M\"\n\n\nfmq_scope\n(character) FMQ scope value to use in table.\n\"NARROW\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_02.html",
    "href": "quarto/table-templates/template-table_02.html",
    "title": "FDA Table 2",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details: make_table_02\nTplyr Table\nTplyr Table Setup\nFunction Details: make_table_02_tplyr\ngtsummary Table\ngtsummary Table Setup\nFunction Details: make_table_02_gtsum\n\n\n\n\n\n\n\n\n\n\n\n                                                  A: Drug X            B: Placebo         C: Combination      Total Population \nCharacteristic                                     (N=134)              (N=134)              (N=132)              (N=400)      \n———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nSex                                                                                                                            \n  F                                                79 (59%)            82 (61.2%)            70 (53%)           231 (57.8%)    \n  M                                                55 (41%)            52 (38.8%)            62 (47%)           169 (42.2%)    \nAge, years                                                                                                                     \n  Mean (SD)                                       33.8 (6.6)           35.4 (7.9)           35.4 (7.7)           34.9 (7.4)    \n  Median (Min - Max)                          33.0 (21.0 - 50.0)   35.0 (21.0 - 62.0)   35.0 (20.0 - 69.0)   34.0 (20.0 - 69.0)\nAge Group, years                                                                                                               \n  &gt;=17 to &lt;65                                     134 (100%)           134 (100%)          131 (99.2%)          399 (99.8%)    \n  &gt;=65                                                0                    0                 1 (0.8%)             1 (0.2%)     \nRace                                                                                                                           \n  ASIAN                                           68 (50.7%)            67 (50%)            73 (55.3%)           208 (52%)     \n  BLACK OR AFRICAN AMERICAN                       31 (23.1%)           28 (20.9%)           32 (24.2%)           91 (22.8%)    \n  WHITE                                           27 (20.1%)           26 (19.4%)           21 (15.9%)           74 (18.5%)    \n  AMERICAN INDIAN OR ALASKA NATIVE                  8 (6%)             11 (8.2%)             6 (4.5%)            25 (6.2%)     \n  MULTIPLE                                            0                 1 (0.7%)                0                 1 (0.2%)     \n  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER           0                 1 (0.7%)                0                 1 (0.2%)     \nEthnicity                                                                                                                      \n   NOT REPORTED                                    6 (4.5%)            10 (7.5%)            11 (8.3%)            27 (6.8%)     \n  HISPANIC OR LATINO                              15 (11.2%)           18 (13.4%)           15 (11.4%)            48 (12%)     \n  NOT HISPANIC OR LATINO                         104 (77.6%)          103 (76.9%)          101 (76.5%)           308 (77%)     \n  UNKNOWN                                          9 (6.7%)             3 (2.2%)             5 (3.8%)            17 (4.2%)     \nCountry of Participation                                                                                                       \n  CHN                                             74 (55.2%)           81 (60.4%)           64 (48.5%)          219 (54.8%)    \n  USA                                             10 (7.5%)            13 (9.7%)            17 (12.9%)            40 (10%)     \n  BRA                                             13 (9.7%)             7 (5.2%)            10 (7.6%)            30 (7.5%)     \n  PAK                                              12 (9%)              9 (6.7%)            10 (7.6%)            31 (7.8%)     \n  NGA                                               8 (6%)              7 (5.2%)            11 (8.3%)            26 (6.5%)     \n  RUS                                              5 (3.7%)              8 (6%)              6 (4.5%)            19 (4.8%)     \n  JPN                                              5 (3.7%)              4 (3%)              9 (6.8%)            18 (4.5%)     \n  GBR                                               4 (3%)              3 (2.2%)             2 (1.5%)             9 (2.2%)     \n  CAN                                              3 (2.2%)             2 (1.5%)             3 (2.3%)              8 (2%)      \nBaseline Temperature (C)                                                                                                       \n  Mean (SD)                                       36.7 (1.0)           36.6 (1.1)           36.5 (1.0)           36.6 (1.0)    \n  Median (Min - Max)                          36.7 (34.0 - 39.3)   36.6 (33.6 - 38.9)   36.5 (34.2 - 38.9)   36.6 (33.6 - 39.3)\n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\nlibrary(dplyr)\n\nadsl &lt;- random.cdisc.data::cadsl\nadvs &lt;- random.cdisc.data::cadvs\n\n# Pre-Processing - Add any variables needed in your table to df\nadsl &lt;- adsl %&gt;%\n  mutate(AGEGR1 = as.factor(case_when(\n    AGE &gt;= 17 & AGE &lt; 65 ~ \"&gt;=17 to &lt;65\",\n    AGE &gt;= 65 ~ \"&gt;=65\",\n    AGE &gt;= 65 & AGE &lt; 75 ~ \"&gt;=65 to &lt;75\",\n    AGE &gt;= 75 ~ \"&gt;=75\"\n  )))\n\nadvs &lt;- advs %&gt;%\n  filter(AVISIT == \"BASELINE\", VSTESTCD == \"TEMP\") %&gt;%\n  select(\"USUBJID\", \"AVAL\")\n\nanl &lt;- left_join(adsl, advs, by = \"USUBJID\")\n\n# Output Table\nmake_table_02(\n  df = anl,\n  vars = c(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\", \"AVAL\"),\n  lbl_vars = c(\n    \"Sex\", \"Age, years\", \"Age Group, years\", \"Race\", \"Ethnicity\",\n    \"Country of Participation\", \"Baseline Temperature (C)\"\n  )\n)\n\n\n\nmake_table_02()\n\nRequired variables:\n\n\ndf: The variables specified by vars, arm_var, and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nvars\n(character) Variables from df to include in the table.\nc(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\")\n\n\nlbl_vars\n(character) Labels corresponding to variables in vars to print in the table. Labels should be ordered according to the order of variables in vars.\nformatters::var_labels(df, fill = TRUE)[vars]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\n\"Total Population\"\n\n\n.stats\n(character) Statistics to include in the table. Includes statistics for all variable types (only the statistics that are valid for a given variable’s type will be printed). See tern::analyze_vars() for options.\nc(\"mean_sd\", \"median_range\", \"count_fraction\")\n\n\n.formats\n(named list of character) List of formats corresponding to each value in .stats. Each name is a value in .stats and the corresponding value is the format that should be applied to that statistic. See formatters::list_valid_format_labels() for a list of valid formats.\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nna_rm\n(flag) Whether NA levels should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here.\n\n\n\n\n\n\n\n\n\n\n\n      A: Drug X\n(N=134)\n      B: Placebo\n(N=134)\n      C: Combination\n(N=132)\n      Total Population\n(N=400)\n    \n\n\nCharacteristic\n\n\n\n\n\n\n  Sex\n\n\n\n\n\n\n    F\n79 (59.0%)\n82 (61.2%)\n70 (53.0%)\n231 (57.8%)\n\n\n    M\n55 (41.0%)\n52 (38.8%)\n62 (47.0%)\n169 (42.2%)\n\n\n  Age, years\n\n\n\n\n\n\n    Mean (SD)\n33.8 ( 6.6)\n35.4 ( 7.9)\n35.4 ( 7.7)\n34.9 ( 7.4)\n\n\n    Median (Min - Max)\n33.0 (21.0 - 50.0)\n35.0 (21.0 - 62.0)\n35.0 (20.0 - 69.0)\n34.0 (20.0 - 69.0)\n\n\n  Age Group, years\n\n\n\n\n\n\n    &gt;=17 to &lt;65\n134 (100.0%)\n134 (100.0%)\n131 (99.2%)\n399 (99.8%)\n\n\n    &gt;=65\n 0 \n 0 \n 1 ( 0.8%)\n 1 ( 0.2%)\n\n\n  Race\n\n\n\n\n\n\n    ASIAN\n68 (50.7%)\n67 (50.0%)\n73 (55.3%)\n208 (52.0%)\n\n\n    BLACK OR AFRICAN AMERICAN\n31 (23.1%)\n28 (20.9%)\n32 (24.2%)\n91 (22.8%)\n\n\n    WHITE\n27 (20.1%)\n26 (19.4%)\n21 (15.9%)\n74 (18.5%)\n\n\n    AMERICAN INDIAN OR ALASKA NATIVE\n 8 ( 6.0%)\n11 ( 8.2%)\n 6 ( 4.5%)\n25 ( 6.2%)\n\n\n    MULTIPLE\n 0 \n 1 ( 0.7%)\n 0 \n 1 ( 0.2%)\n\n\n    NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER\n 0 \n 1 ( 0.7%)\n 0 \n 1 ( 0.2%)\n\n\n  Ethnicity\n\n\n\n\n\n\n     NOT REPORTED\n 6 ( 4.5%)\n10 ( 7.5%)\n11 ( 8.3%)\n27 ( 6.8%)\n\n\n    HISPANIC OR LATINO\n15 (11.2%)\n18 (13.4%)\n15 (11.4%)\n48 (12.0%)\n\n\n    NOT HISPANIC OR LATINO\n104 (77.6%)\n103 (76.9%)\n101 (76.5%)\n308 (77.0%)\n\n\n    UNKNOWN\n 9 ( 6.7%)\n 3 ( 2.2%)\n 5 ( 3.8%)\n17 ( 4.2%)\n\n\n  Country of Participation\n\n\n\n\n\n\n    CHN\n74 (55.2%)\n81 (60.4%)\n64 (48.5%)\n219 (54.8%)\n\n\n    USA\n10 ( 7.5%)\n13 ( 9.7%)\n17 (12.9%)\n40 (10.0%)\n\n\n    BRA\n13 ( 9.7%)\n 7 ( 5.2%)\n10 ( 7.6%)\n30 ( 7.5%)\n\n\n    PAK\n12 ( 9.0%)\n 9 ( 6.7%)\n10 ( 7.6%)\n31 ( 7.8%)\n\n\n    NGA\n 8 ( 6.0%)\n 7 ( 5.2%)\n11 ( 8.3%)\n26 ( 6.5%)\n\n\n    RUS\n 5 ( 3.7%)\n 8 ( 6.0%)\n 6 ( 4.5%)\n19 ( 4.8%)\n\n\n    JPN\n 5 ( 3.7%)\n 4 ( 3.0%)\n 9 ( 6.8%)\n18 ( 4.5%)\n\n\n    GBR\n 4 ( 3.0%)\n 3 ( 2.2%)\n 2 ( 1.5%)\n 9 ( 2.2%)\n\n\n    CAN\n 3 ( 2.2%)\n 2 ( 1.5%)\n 3 ( 2.3%)\n 8 ( 2.0%)\n\n\n  Baseline Temperature (C)\n\n\n\n\n\n\n    Mean (SD)\n36.7 ( 1.0)\n36.6 ( 1.1)\n36.5 ( 1.0)\n36.6 ( 1.0)\n\n\n    Median (Min - Max)\n36.7 (34.0 - 39.3)\n36.6 (33.6 - 38.9)\n36.5 (34.2 - 38.9)\n36.6 (33.6 - 39.3)\n\n\n\n\n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\nlibrary(dplyr)\n\nadsl &lt;- random.cdisc.data::cadsl\nadvs &lt;- random.cdisc.data::cadvs\n\n# Pre-Processing - Add any variables needed in your table to df\nadsl &lt;- adsl %&gt;%\n  mutate(AGEGR1 = as.factor(case_when(\n    AGE &gt;= 17 & AGE &lt; 65 ~ \"&gt;=17 to &lt;65\",\n    AGE &gt;= 65 ~ \"&gt;=65\",\n    AGE &gt;= 65 & AGE &lt; 75 ~ \"&gt;=65 to &lt;75\",\n    AGE &gt;= 75 ~ \"&gt;=75\"\n  )))\n\nadvs &lt;- advs %&gt;%\n  filter(AVISIT == \"BASELINE\", VSTESTCD == \"TEMP\") %&gt;%\n  select(\"USUBJID\", \"AVAL\")\n\nanl &lt;- left_join(adsl, advs, by = \"USUBJID\")\n\n# Output Table\nmake_table_02_tplyr(\n  df = anl,\n  vars = c(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\", \"AVAL\"),\n  lbl_vars = c(\n    \"Sex\", \"Age, years\", \"Age Group, years\", \"Race\", \"Ethnicity\",\n    \"Country of Participation\", \"Baseline Temperature (C)\"\n  )\n)\n\n\n\nmake_table_02_tplyr()\n\nRequired variables:\n\n\ndf: SAFFL and the variables specified by vars and arm_var.\n\nalt_counts_df (if specified and tplyr_raw = FALSE): SAFFL, USUBJID, and the variable specified by arm_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nvars\n(character) Variables from df to include in the table.\nc(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\")\n\n\nlbl_vars\n(character) Labels corresponding to variables in vars to print in the table. Labels should be ordered according to the order of variables in vars.\nformatters::var_labels(df, fill = TRUE)[vars]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\n\"Total Population\"\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nna_rm\n(flag) Whether NA levels should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title and subtitles. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\ntplyr_raw\n(flag) Whether the raw tibble created using Tplyr functions should be returned, or the table formatted using functions from tfrmt should be returned (default).\nFALSE\n\n\n\nSource code for this function is available here.\n\n\n\n\n\n\n\n\n\n\nCharacteristic\n      \nA: Drug X\nN = 134\n      \nB: Placebo\nN = 134\n      \nC: Combination\nN = 132\n      \nTotal Population\nN = 400\n    \n\n\nSex, n (%)\n\n\n\n\n\n\n    F\n79 (59%)\n82 (61%)\n70 (53%)\n231 (58%)\n\n\n    M\n55 (41%)\n52 (39%)\n62 (47%)\n169 (42%)\n\n\nAge, years\n\n\n\n\n\n\n    Mean (SD)\n33.8 (6.6)\n35.4 (7.9)\n35.4 (7.7)\n34.9 (7.4)\n\n\n    Median (min - max)\n33.0 (21.0 - 50.0)\n35.0 (21.0 - 62.0)\n35.0 (20.0 - 69.0)\n34.0 (20.0 - 69.0)\n\n\nAge Group years, n (%)\n\n\n\n\n\n\n    ≥17 to &lt;65\n134 (100%)\n134 (100%)\n131 (99%)\n399 (100%)\n\n\n    ≥65\n0 (0%)\n0 (0%)\n1 (0.8%)\n1 (0.3%)\n\n\nRace, n (%)\n\n\n\n\n\n\n    ASIAN\n68 (51%)\n67 (50%)\n73 (55%)\n208 (52%)\n\n\n    BLACK OR AFRICAN AMERICAN\n31 (23%)\n28 (21%)\n32 (24%)\n91 (23%)\n\n\n    WHITE\n27 (20%)\n26 (19%)\n21 (16%)\n74 (19%)\n\n\n    AMERICAN INDIAN OR ALASKA NATIVE\n8 (6.0%)\n11 (8.2%)\n6 (4.5%)\n25 (6.3%)\n\n\n    MULTIPLE\n0 (0%)\n1 (0.7%)\n0 (0%)\n1 (0.3%)\n\n\n    NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER\n0 (0%)\n1 (0.7%)\n0 (0%)\n1 (0.3%)\n\n\n    OTHER\n0 (0%)\n0 (0%)\n0 (0%)\n0 (0%)\n\n\n    UNKNOWN\n0 (0%)\n0 (0%)\n0 (0%)\n0 (0%)\n\n\nEthnicity, n (%)\n\n\n\n\n\n\n     NOT REPORTED\n6 (4.5%)\n10 (7.5%)\n11 (8.3%)\n27 (6.8%)\n\n\n    HISPANIC OR LATINO\n15 (11%)\n18 (13%)\n15 (11%)\n48 (12%)\n\n\n    NOT HISPANIC OR LATINO\n104 (78%)\n103 (77%)\n101 (77%)\n308 (77%)\n\n\n    UNKNOWN\n9 (6.7%)\n3 (2.2%)\n5 (3.8%)\n17 (4.3%)\n\n\nCountry of Participation, n (%)\n\n\n\n\n\n\n    CHN\n74 (55%)\n81 (60%)\n64 (48%)\n219 (55%)\n\n\n    USA\n10 (7.5%)\n13 (9.7%)\n17 (13%)\n40 (10%)\n\n\n    BRA\n13 (9.7%)\n7 (5.2%)\n10 (7.6%)\n30 (7.5%)\n\n\n    PAK\n12 (9.0%)\n9 (6.7%)\n10 (7.6%)\n31 (7.8%)\n\n\n    NGA\n8 (6.0%)\n7 (5.2%)\n11 (8.3%)\n26 (6.5%)\n\n\n    RUS\n5 (3.7%)\n8 (6.0%)\n6 (4.5%)\n19 (4.8%)\n\n\n    JPN\n5 (3.7%)\n4 (3.0%)\n9 (6.8%)\n18 (4.5%)\n\n\n    GBR\n4 (3.0%)\n3 (2.2%)\n2 (1.5%)\n9 (2.3%)\n\n\n    CAN\n3 (2.2%)\n2 (1.5%)\n3 (2.3%)\n8 (2.0%)\n\n\n    CHE\n0 (0%)\n0 (0%)\n0 (0%)\n0 (0%)\n\n\nBaseline Temperature (C)\n\n\n\n\n\n\n    Mean (SD)\n36.7 (1.0)\n36.6 (1.1)\n36.5 (1.0)\n36.6 (1.0)\n\n\n    Median (min - max)\n36.7 (34.0 - 39.3)\n36.6 (33.6 - 38.9)\n36.5 (34.2 - 38.9)\n36.6 (33.6 - 39.3)\n\n\n\n\n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\nlibrary(dplyr)\n\nadsl &lt;- random.cdisc.data::cadsl\nadvs &lt;- random.cdisc.data::cadvs\n\n# Pre-Processing - Add any variables needed in your table to df\nadsl &lt;- adsl %&gt;%\n  mutate(AGEGR1 = as.factor(case_when(\n    AGE &gt;= 17 & AGE &lt; 65 ~ \"≥17 to &lt;65\",\n    AGE &gt;= 65 ~ \"≥65\",\n    AGE &gt;= 65 & AGE &lt; 75 ~ \"≥65 to &lt;75\",\n    AGE &gt;= 75 ~ \"≥75\"\n  )))\n\nadvs &lt;- advs %&gt;%\n  filter(AVISIT == \"BASELINE\", VSTESTCD == \"TEMP\") %&gt;%\n  select(\"USUBJID\", \"AVAL\")\n\nanl &lt;- left_join(adsl, advs, by = \"USUBJID\")\n\n# Output Table\nmake_table_02_gtsum(\n  df = anl,\n  vars = c(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\", \"AVAL\"),\n  lbl_vars = c(\n    \"Sex\", \"Age, years\", \"Age Group years\", \"Race\", \"Ethnicity\",\n    \"Country of Participation\", \"Baseline Temperature (C)\"\n  )\n)\n\n\n\nmake_table_02_gtsum()\n\nRequired variables:\n\n\ndf: SAFFL and the variables specified by vars and arm_var.\n\nalt_counts_df (if specified and tplyr_raw = FALSE): SAFFL, USUBJID, and the variable specified by arm_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nvars\n(character) Variables from df to include in the table.\nc(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\")\n\n\nlbl_vars\n(character) Labels corresponding to variables in vars to print in the table. Labels should be ordered according to the order of variables in vars.\nformatters::var_labels(df, fill = TRUE)[vars]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\n\"Total Population\"\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_32.html",
    "href": "quarto/table-templates/template-table_32.html",
    "title": "FDA Table 32",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\ngtsummary Table\ngtsummary Table Setup\nFunction Details: make_table_32_gtsum\n\n\n\n\n\n\n\n\n\n\n\nDiastolic Blood Pressure    A: Drug X    B: Placebo    C: Combination   Risk Difference (%) (95% CI)\n(Pa)                         (N=134)       (N=134)        (N=132)                 (N=268)           \n————————————————————————————————————————————————————————————————————————————————————————————————————\n&lt;60                             0             0              0                0.0 (0.0 - 0.0)       \n&gt;60                        134 (100%)    134 (100%)      132 (100%)           0.0 (0.0 - 0.0)       \n&gt;90                        134 (100%)    134 (100%)     131 (99.2%)           0.0 (0.0 - 0.0)       \n&gt;110                       123 (91.8%)   111 (82.8%)    107 (81.1%)         -9.0 (-16.9 - -1.1)     \n&gt;=120                      88 (65.7%)    70 (52.2%)      76 (57.6%)         -13.4 (-25.1 - -1.8)    \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadvs &lt;- random.cdisc.data::cadvs\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_32(advs = advs, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_32()\n\nRequired variables:\n\n\nadvs: USUBJID, AVISITN, PARAMCD, AVAL, AVALU, and the variables specified by arm_var and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadvs\n(data.frame) Dataset (typically ADVS) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here.\n\n\n\n\n\n\n\n\n\n\nDiastolic Blood Pressure (Pa)\n      \nA: Drug X\nN = 134\n      \nB: Placebo\nN = 134\n      \nC: Combination\nN = 132\n    \n\n\n&lt;60\n0 (0.0%)\n0 (0.0%)\n0 (0.0%)\n\n\n&gt;60\n134 (100.0%)\n134 (100.0%)\n132 (100.0%)\n\n\n&gt;90\n134 (100.0%)\n134 (100.0%)\n131 (99.2%)\n\n\n&gt;110\n123 (91.8%)\n111 (82.8%)\n107 (81.1%)\n\n\n&gt;=120\n88 (65.7%)\n70 (52.2%)\n76 (57.6%)\n\n\n\n\n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadvs &lt;- random.cdisc.data::cadvs\n\n# Output table\ntbl &lt;- make_table_32_gtsum(advs = advs)\ntbl\n\n\n\nmake_table_32_gtsum()\n\nRequired variables:\n\n\nadvs: USUBJID, AVISITN, PARAMCD, AVAL, AVALU, and the variables specified by arm_var and saffl_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadvs\n(data.frame) Dataset (typically ADVS) required to build table.\nNo default\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\n\"Total Population\"\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_21.html",
    "href": "quarto/table-templates/template-table_21.html",
    "title": "FDA Table 21",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                               A: Drug X    B: Placebo    C: Combination\nCharacteristic                                  (N=134)       (N=134)        (N=132)    \n————————————————————————————————————————————————————————————————————————————————————————\nAny SAE                                       104 (77.6%)   101 (75.4%)     99 (75.0%)  \nSEX                                                                                     \n  F                                           61 (77.2%)     64 (78%)       50 (71.4%)  \n  M                                           43 (78.2%)    37 (71.2%)       49 (79%)   \nAge Group, years                                                                        \n  &gt;=17 to &lt;65                                 104 (77.6%)   101 (75.4%)     98 (74.8%)  \n  &gt;=65                                             0             0           1 (100%)   \nRACE                                                                                    \n  ASIAN                                       52 (76.5%)    46 (68.7%)      51 (69.9%)  \n  BLACK OR AFRICAN AMERICAN                   23 (74.2%)    23 (82.1%)      26 (81.2%)  \n  WHITE                                       22 (81.5%)    22 (84.6%)       17 (81%)   \n  AMERICAN INDIAN OR ALASKA NATIVE             7 (87.5%)     8 (72.7%)      5 (83.3%)   \n  MULTIPLE                                         0         1 (100%)           0       \n  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER        0         1 (100%)           0       \n  OTHER                                            0             0              0       \n  UNKNOWN                                          0             0              0       \nETHNIC                                                                                  \n   NOT REPORTED                                6 (100%)       7 (70%)       7 (63.6%)   \n  HISPANIC OR LATINO                          11 (73.3%)    13 (72.2%)      11 (73.3%)  \n  NOT HISPANIC OR LATINO                      81 (77.9%)    80 (77.7%)      78 (77.2%)  \n  UNKNOWN                                      6 (66.7%)     1 (33.3%)       3 (60%)    \n\n\n\n\n\n# Load Libraries & Data\nlibrary(dplyr)\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl %&gt;%\n  mutate(AGEGR1 = as.factor(case_when(\n    AGE &gt;= 17 & AGE &lt; 65 ~ \"&gt;=17 to &lt;65\",\n    AGE &gt;= 65 ~ \"&gt;=65\",\n    AGE &gt;= 65 & AGE &lt; 75 ~ \"&gt;=65 to &lt;75\",\n    AGE &gt;= 75 ~ \"&gt;=75\"\n  )) %&gt;% formatters::with_label(\"Age Group, years\")) %&gt;%\n  formatters::var_relabel(\n    AGE = \"Age, years\"\n  )\n\nadae &lt;- random.cdisc.data::cadae\nadae$ASER &lt;- adae$AESER\n\ndf &lt;- left_join(adsl, adae, by = intersect(names(adsl), names(adae)))\n\n# Output Table\nmake_table_21(df = df, alt_counts_df = adsl, denom = \"N_s\")\n\n\n\nmake_table_21()\n\nRequired variables:\n\n\ndf: USUBJID, ASER, and the variables specified by arm_var and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\nmake_table_21() inherits from falcon::a_count_occurrences_ser_ae() function.\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nvars\n(character) Variables from df to include in the table.\nc(\"SEX\", \"AGE\", \"AGEGR1\", \"RACE\", \"ETHNIC\", \"COUNTRY\")\n\n\ndenom\n(character) Denominator choice (N_col to get the total column, n to have the total number of “Any SAE” in the column, or N_s to have the total number of participants of the category in the column as denominator).\nc(\"N_s\", \"N_col\", \"n\")\n\n\nlbl_vars\n(character) Labels corresponding to variables in vars to print in the table. Labels should be ordered according to the order of variables in vars.\nformatters::var_labels(df, fill = TRUE)[vars]\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_12.html",
    "href": "quarto/table-templates/template-table_12.html",
    "title": "FDA Table 12",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nBody System or Organ Class                                 A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  Dictionary-Derived Term                                   (N=134)      (N=134)        (N=132)                 (N=268)           \n——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\nPatients with at least one AE leading to discontinuation   86 (64.2%)   93 (69.4%)     90 (68.2%)          5.2 (-6.0 - 16.5)      \ncl A.1                                                     53 (39.6%)   55 (41.0%)     69 (52.3%)          1.5 (-10.3 - 13.2)     \n  dcd A.1.1.1.1                                            37 (27.6%)   37 (27.6%)     50 (37.9%)          0.0 (-10.7 - 10.7)     \n  dcd A.1.1.1.2                                            33 (24.6%)   31 (23.1%)     40 (30.3%)          -1.5 (-11.7 - 8.7)     \ncl B.1                                                     35 (26.1%)   41 (30.6%)     36 (27.3%)          4.5 (-6.3 - 15.3)      \n  dcd B.1.1.1.1                                            35 (26.1%)   41 (30.6%)     36 (27.3%)          4.5 (-6.3 - 15.3)      \ncl B.2                                                     55 (41.0%)   56 (41.8%)     65 (49.2%)          0.7 (-11.0 - 12.5)     \n  dcd B.2.1.2.1                                            36 (26.9%)   33 (24.6%)     35 (26.5%)          -2.2 (-12.7 - 8.2)     \n  dcd B.2.2.3.1                                            34 (25.4%)   41 (30.6%)     41 (31.1%)          5.2 (-5.5 - 16.0)      \ncl C.1                                                     28 (20.9%)   36 (26.9%)     32 (24.2%)          6.0 (-4.2 - 16.2)      \n  dcd C.1.1.1.3                                            28 (20.9%)   36 (26.9%)     32 (24.2%)          6.0 (-4.2 - 16.2)      \ncl C.2                                                     26 (19.4%)   39 (29.1%)     43 (32.6%)          9.7 (-0.5 - 19.9)      \n  dcd C.2.1.2.1                                            26 (19.4%)   39 (29.1%)     43 (32.6%)          9.7 (-0.5 - 19.9)      \ncl D.1                                                     51 (38.1%)   51 (38.1%)     60 (45.5%)          0.0 (-11.6 - 11.6)     \n  dcd D.1.1.1.1                                            29 (21.6%)   31 (23.1%)     37 (28.0%)          1.5 (-8.5 - 11.5)      \n  dcd D.1.1.4.2                                            33 (24.6%)   34 (25.4%)     39 (29.5%)          0.7 (-9.6 - 11.1)      \ncl D.2                                                     35 (26.1%)   46 (34.3%)     44 (33.3%)          8.2 (-2.7 - 19.2)      \n  dcd D.2.1.5.3                                            35 (26.1%)   46 (34.3%)     44 (33.3%)          8.2 (-2.7 - 19.2)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variable DCSREAS exist in adae\nadae$DCSREAS[is.na(adae$DCSREAS)] &lt;- \"ADVERSE EVENT\"\n\n# Select Preferred Term Variable\npref_var &lt;- \"AEDECOD\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_12(adae = adae, alt_counts_df = adsl, pref_var = pref_var, risk_diff = risk_diff)\n\n\n\nmake_table_12()\n\nRequired variables:\n\n\nadae: USUBJID, AEBODSYS, DCSREAS, and the variables specified by pref_var, arm_var, and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable from adae to include in the table.\n\"AEDECOD\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_33.html",
    "href": "quarto/table-templates/template-table_33.html",
    "title": "FDA Table 33",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nBlood Pressure    A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n(Pa)               (N=134)      (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————\nSBP &lt;90          85 (63.4%)    84 (62.7%)     90 (68.2%)         -0.7 (-12.3 - 10.8)     \nDBP &lt;60          133 (99.3%)   134 (100%)     132 (100%)           0.7 (-0.7 - 2.2)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadvs &lt;- random.cdisc.data::cadvs\nadvs$AVAL &lt;- advs$AVAL - 100\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_33(advs = advs, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_33()\n\nRequired variables:\n\n\nadvs: USUBJID, AVISITN, PARAMCD, AVAL, AVALU, and the variables specified by arm_var and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadvs\n(data.frame) Dataset (typically ADVS) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_14.html",
    "href": "quarto/table-templates/template-table_14.html",
    "title": "FDA Table 14",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                                              BROAD                                                                    NARROW                                 \nBody System or Organ Class   A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)   A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  FMQ                         (N=119)      (N=139)        (N=141)                 (N=258)               (N=490)      (N=483)        (N=562)                 (N=973)           \n——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————\ncl A.1                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI       0            0              0                0.0 (0.0 - 0.0)              0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)          78 (15.9%)   75 (15.5%)     89 (15.8%)          -0.4 (-5.0 - 4.2)      \ncl B.1                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI       0            0              0                0.0 (0.0 - 0.0)              0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)          47 (9.6%)    49 (10.1%)     43 (7.7%)            0.6 (-3.2 - 4.3)      \ncl B.2                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI   48 (40.3%)   54 (38.8%)     51 (36.2%)         -1.5 (-13.5 - 10.5)            0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)          49 (10.0%)   44 (9.1%)      52 (9.3%)           -0.9 (-4.6 - 2.8)      \ncl C.1                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI   43 (36.1%)   46 (33.1%)     43 (30.5%)          -3.0 (-14.7 - 8.6)            0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)              0            0              0                0.0 (0.0 - 0.0)       \ncl C.2                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI       0            0              0                0.0 (0.0 - 0.0)              0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)          35 (7.1%)    48 (9.9%)      55 (9.8%)            2.8 (-0.7 - 6.3)      \ncl D.1                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI       0            0              0                0.0 (0.0 - 0.0)              0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)          79 (16.1%)   67 (13.9%)     80 (14.2%)          -2.3 (-6.7 - 2.2)      \ncl D.2                                                                                                                                                                        \n  C.1.1.1.3/B.2.2.3.1 AESI       0            0              0                0.0 (0.0 - 0.0)              0            0              0                0.0 (0.0 - 0.0)       \n  &lt;Missing&gt;                      0            0              0                0.0 (0.0 - 0.0)          47 (9.6%)    58 (12.0%)     57 (10.1%)           2.4 (-1.5 - 6.3)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables FMQ01SC and FMQ01NAM exist in adae\nadae &lt;- dplyr::rename(adae, FMQ01SC = SMQ01SC, FMQ01NAM = SMQ01NAM)\nlevels(adae$FMQ01SC) &lt;- c(\"BROAD\", \"NARROW\")\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_14(adae = adae, risk_diff = risk_diff)\n\n\n\nmake_table_14()\n\nRequired variables:\n\n\nadae: USUBJID, AEBODSYS, and the variables specified by arm_var, saffl_var, fmqsc_var, and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_03.html",
    "href": "quarto/table-templates/template-table_03.html",
    "title": "FDA Table 3",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nDisposition                              A: Drug X    B: Placebo    C: Combination\n——————————————————————————————————————————————————————————————————————————————————\nPatients screened                           134           134            132      \nScreening failures                       42 (31.3%)   32 (23.9%)      26 (19.7%)  \n  Inclusion/exclusion criteria not met    6 (4.5%)     10 (7.5%)      10 (7.6%)   \n  Patient noncompliance                  12 (9.0%)     2 (1.5%)        6 (4.5%)   \n  Consent withdrawn                      13 (9.7%)     12 (9.0%)       5 (3.8%)   \n  Other                                  11 (8.2%)     8 (6.0%)        5 (3.8%)   \nPatients enrolled                        92 (68.7%)   102 (76.1%)    106 (80.3%)  \nPatients randomized                      92 (68.7%)   102 (76.1%)    106 (80.3%)  \n\n\n\n\n\n# Load Libraries & Data\nlibrary(dplyr)\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\n\n# Pre-Processing - Add all required screening variables are in df\nset.seed(1)\nadsl &lt;- random.cdisc.data::cadsl\nadsl$RANDDT[sample(seq_len(nrow(adsl)), 100)] &lt;- NA\nadsl &lt;- adsl %&gt;%\n  mutate(\n    ENRLDT = RANDDT,\n    SCRNFL = \"Y\",\n    SCRNFRS = factor(sample(\n      c(\"Inclusion/exclusion criteria not met\", \"Patient noncompliance\", \"Consent withdrawn\", \"Other\"),\n      size = nrow(adsl), replace = TRUE\n    ), levels = c(\"Inclusion/exclusion criteria not met\", \"Patient noncompliance\", \"Consent withdrawn\", \"Other\")),\n    SCRNFAILFL = ifelse(is.na(ENRLDT), \"Y\", \"N\")\n  )\nadsl$SCRNFRS[adsl$SCRNFL == \"N\" | !is.na(adsl$ENRLDT)] &lt;- NA\n\n# Output Table\nmake_table_03(df = adsl, scrnfl_var = \"SCRNFL\", scrnfailfl_var = \"SCRNFAILFL\", scrnfail_var = \"SCRNFRS\")\n\n\n\nmake_table_3()\n\nRequired variables:\n\n\nadsl: USUBJID, ENRLDT, RANDDT, and the variables specified by arm_var, scrnfl_var, scrnfailfl_var, and scrnfail_var.\n\nalt_counts_df (if specified): USUBJID, and the variable specified by arm_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadsl\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nFALSE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nscrnfl_var\n(character) Variable from df that indicates whether patients were screened.\nNo default\n\n\nscrnfailfl_var\n(character) Variable from df that indicates screening failure.\nNo default\n\n\nscrnfail_var\n(character) Variable from df that contains reasons for screening failure.\nNo default\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_07.html",
    "href": "quarto/table-templates/template-table_07.html",
    "title": "FDA Table 7",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n                                  A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\nDeaths                             (N=134)      (N=134)        (N=132)                 (N=268)           \n—————————————————————————————————————————————————————————————————————————————————————————————————————————\nTotal deaths                      24 (17.9%)   19 (14.2%)     20 (15.2%)          -3.7 (-12.5 - 5.0)     \n  ADVERSE EVENT                   8 (33.3%)    6 (31.6%)      10 (50.0%)          -1.5 (-6.8 - 3.8)      \n  DISEASE PROGRESSION             8 (33.3%)    5 (26.3%)      6 (30.0%)           -2.2 (-7.4 - 2.9)      \n  LOST TO FOLLOW UP                2 (8.3%)     1 (5.3%)       1 (5.0%)           -0.7 (-3.3 - 1.8)      \n  MISSING                          2 (8.3%)    3 (15.8%)       1 (5.0%)            0.7 (-2.5 - 4.0)      \n  Post-study reporting of death    1 (4.2%)     1 (5.3%)       1 (5.0%)            0.0 (-2.1 - 2.1)      \n  SUICIDE                          2 (8.3%)    2 (10.5%)       1 (5.0%)            0.0 (-2.9 - 2.9)      \n  UNKNOWN                          1 (4.2%)     1 (5.3%)          0                0.0 (-2.1 - 2.1)      \nTreatment-emergent deaths         12 (9.0%)    15 (11.2%)     16 (12.1%)           2.2 (-5.0 - 9.4)      \n  ADVERSE EVENT                   3 (25.0%)    5 (33.3%)      9 (56.2%)            1.5 (-2.6 - 5.6)      \n  DISEASE PROGRESSION             3 (25.0%)    5 (33.3%)      4 (25.0%)            1.5 (-2.6 - 5.6)      \n  LOST TO FOLLOW UP                1 (8.3%)        0              0               -0.7 (-2.2 - 0.7)      \n  MISSING                         2 (16.7%)     1 (6.7%)       1 (6.2%)           -0.7 (-3.3 - 1.8)      \n  Post-study reporting of death       0         1 (6.7%)       1 (6.2%)            0.7 (-0.7 - 2.2)      \n  SUICIDE                         2 (16.7%)    2 (13.3%)       1 (6.2%)            0.0 (-2.9 - 2.9)      \n  UNKNOWN                          1 (8.3%)     1 (6.7%)          0                0.0 (-2.1 - 2.1)      \nNontreatment-emergent deaths      12 (9.0%)     4 (3.0%)       4 (3.0%)          -6.0 (-11.6 - -0.3)     \n  ADVERSE EVENT                   5 (41.7%)    1 (25.0%)      1 (25.0%)           -3.0 (-6.5 - 0.5)      \n  DISEASE PROGRESSION             5 (41.7%)        0          2 (50.0%)           -3.7 (-6.9 - -0.5)     \n  LOST TO FOLLOW UP                1 (8.3%)    1 (25.0%)      1 (25.0%)            0.0 (-2.1 - 2.1)      \n  MISSING                             0        2 (50.0%)          0                1.5 (-0.6 - 3.5)      \n  Post-study reporting of death    1 (8.3%)        0              0               -0.7 (-2.2 - 0.7)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure all required variables are present in adae\nset.seed(1)\nadae$TRTEMFL &lt;- ifelse(adae$USUBJID %in% sample(adsl$USUBJID, size = as.integer(nrow(adsl) / 3)), \"N\", \"Y\")\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\") # optional\nmake_table_07(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_07()\n\nRequired variables:\n\n\nadae: USUBJID, TRTEMFL, DTHFL, DTHCAUS, and the variables specified by arm_var and saffl_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset (typically ADSL) used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nTRUE\n\n\nna_level\n(character) String to represent missing values.\n\"MISSING\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/table-templates/template-table_18.html",
    "href": "quarto/table-templates/template-table_18.html",
    "title": "FDA Table 18",
    "section": "",
    "text": "Spec. Screenshot\nrtables/tern Table\nrtables/tern Table Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\nFMQ (Broad)                    A: Drug X    B: Placebo   C: Combination   Risk Difference (%) (95% CI)\n  Preferred Term                (N=134)      (N=134)        (N=132)                 (N=268)           \n——————————————————————————————————————————————————————————————————————————————————————————————————————\nAbnormal Uterine Bleeding                                                                             \n  dcd B.2.2.3.1                 6 (4.5%)    14 (10.4%)      6 (4.5%)           6.0 (-0.3 - 12.2)      \n  dcd C.1.1.1.3                14 (10.4%)   13 (9.7%)      10 (7.6%)           -0.7 (-8.0 - 6.5)      \nAmenorrhea                                                                                            \n  dcd B.2.2.3.1                12 (9.0%)    10 (7.5%)      10 (7.6%)           -1.5 (-8.1 - 5.1)      \n  dcd C.1.1.1.3                13 (9.7%)    11 (8.2%)      10 (7.6%)           -1.5 (-8.3 - 5.3)      \nBacterial Vaginosis                                                                                   \n  dcd B.2.2.3.1                10 (7.5%)    10 (7.5%)       8 (6.1%)            0.0 (-6.3 - 6.3)      \n  dcd C.1.1.1.3                 8 (6.0%)    13 (9.7%)       5 (3.8%)           3.7 (-2.7 - 10.2)      \nDecreased Menstrual Bleeding                                                                          \n  dcd B.2.2.3.1                10 (7.5%)     5 (3.7%)       9 (6.8%)           -3.7 (-9.2 - 1.8)      \n  dcd C.1.1.1.3                 3 (2.2%)    10 (7.5%)      12 (9.1%)            5.2 (0.1 - 10.3)      \n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadae &lt;- random.cdisc.data::cadae\n\n# Pre-Processing - Ensure required variables FMQ01SC and FMQ01NAM exist in adae\nset.seed(1)\nadae &lt;- dplyr::rename(adae, FMQ01SC = SMQ01SC, FMQ01NAM = SMQ01NAM)\nlevels(adae$FMQ01SC) &lt;- c(\"BROAD\", \"NARROW\")\nadae$FMQ01SC[is.na(adae$FMQ01SC)] &lt;- \"NARROW\"\nadae$FMQ01NAM &lt;- factor(adae$FMQ01NAM, levels = c(\n  unique(adae$FMQ01NAM), \"Abnormal Uterine Bleeding\", \"Amenorrhea\",\n  \"Bacterial Vaginosis\", \"Decreased Menstrual Bleeding\"\n))\nadae$FMQ01NAM[adae$SEX == \"F\"] &lt;- as.factor(\n  sample(c(\n    \"Abnormal Uterine Bleeding\", \"Amenorrhea\",\n    \"Bacterial Vaginosis\", \"Decreased Menstrual Bleeding\"\n  ), sum(adae$SEX == \"F\"), replace = TRUE)\n)\n\n# Output Table\nrisk_diff &lt;- list(arm_x = \"B: Placebo\", arm_y = \"A: Drug X\")\nmake_table_18(adae = adae, alt_counts_df = adsl, risk_diff = risk_diff)\n\n\n\nmake_table_18()\n\nRequired variables:\n\n\nadae: adae must contain USUBJID, SEX, and the variables specified by arm_var, saffl_var, pref_var, fmqsc_var and fmqnam_var.\n\nalt_counts_df (if specified): USUBJID and the variables specified by arm_var and saffl_var.\n\n\n\nArgument\nDescription\nDefault\n\n\n\nadae\n(data.frame) Dataset (typically ADAE) required to build table.\nNo default\n\n\nalt_counts_df\n(character) Alternative dataset used only to calculate column counts.\nNULL\n\n\nshow_colcounts\n(flag) Whether column counts should be printed.\nTRUE\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\npref_var\n(character) Preferred term variable to use in table.\n\"AEDECOD\"\n\n\nsex_scope\n(character) Level of SEX to output in table.\n\"F\"\n\n\nfmq_scope\n(character) FMQ scope value to use in table.\n\"BROAD\"\n\n\nfmqsc_var\n(character) FMQ scope variable to use in table.\n\"FMQ01SC\"\n\n\nfmqnam_var\n(character) FMQ reference name variable to use in table.\n\"FMQ01NAM\"\n\n\nlbl_overall\n(character) If specified, an overall column will be added to the table with the given value as the column label.\nNULL\n\n\nrisk_diff\n\n(named list) List of settings to apply to add a risk difference column to the table. See tern::add_riskdiff() for more details. List should contain the following elements:\n\narm_x: (required) the name of reference arm.\narm_y: (required) the name of the arm to compare to the reference arm.\ncol_label: (optional) label to use for the risk difference column. Defaults to \"Risk Difference (%) (95% CI)\".\npct: (optional) whether the output should be returned as percentages. Defaults to TRUE.\n\n\nNULL\n\n\nprune_0\n(flag) Whether all-zero rows should be removed from the table.\nFALSE\n\n\nna_level\n(character) String to represent missing values.\n\"&lt;Missing&gt;\"\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, main_footer, and prov_footer. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/figure-templates/template-fig_01.html",
    "href": "quarto/figure-templates/template-fig_01.html",
    "title": "FDA Figure 1",
    "section": "",
    "text": "Spec. Screenshot\nggplot2 Figure\nFigure Setup\nFunction Details\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n# Load Libraries & Data\nlibrary(falcon)\n\nadsl &lt;- random.cdisc.data::cadsl\nadsl$TRTSDTM &lt;- adsl$TRTSDTM[1]\nadsl$TRTEDTM &lt;- adsl$TRTSDTM + lubridate::days(sample(0:400, nrow(adsl), replace = TRUE))\n\n# Output Figure\nmake_fig_01(df = adsl)\n\n\n\nmake_fig_01()\n\nRequired variables:\n\n\ndf: The variables specified by arm_var, id_var, saffl_var, trtsdtm_var, and trtedtm_var.\n\n\n\n\n\n\n\n\nArgument\nDescription\nDefault\n\n\n\ndf\n(data.frame) Dataset (typically ADSL) required to build table.\nNo default\n\n\narm_var\n(character) Arm variable used to split table into columns.\n\"ARM\"\n\n\nsaffl_var\n(character) Flag variable used to indicate inclusion in safety population.\n\"SAFFL\"\n\n\nid_var\n(character) Identifier variable used to count the participants within each flag.\n\"USUBJID\"\n\n\ntrtsdtm_var\n(character) Treatment start datetime variable in df.\n\"TRTSDTM\"\n\n\ntrtedtm_var\n(character) Treatment end datetime variable in df.\n\"TRTEDTM\"\n\n\nu_trtdur\n(character) Unit for duration of treatment. Options are \"days\", \"weeks\", \"months\" and \"years\".\n\"days\"\n\n\nx_lab\n(character) x-axis label.\npaste0(\"Time from first dose (\", u_trtdur, \")\")\n\n\ny_lab\n(character) y-axis label.\n\"Percent of Patients (%)\"\n\n\nxticks\n(vector of numeric) x-axis tick positions. If NA (default), tick mark positions are automatically calculated.\nNA\n\n\nadd_table\n(flag) whether “Number of Patients” table should be printed under the plot.\nTRUE\n\n\nannotations\n(named list of character) List of annotations to add to the table. Valid annotation types are title, subtitles, and caption. Each name-value pair should use the annotation type as name and the desired string as value.\nNULL\n\n\n\nSource code for this function is available here."
  },
  {
    "objectID": "quarto/faq.html",
    "href": "quarto/faq.html",
    "title": "Frequently Asked Questions",
    "section": "",
    "text": "1.  How do I install the falcon package?\nFor instructions on installing the falcon package please see the Environment Setup and Package Installation section of the Getting Started page. \n\n\n2.  How can I join this initiative?\nFor information on how to join the falcon initiative please see the Joining as a Collaborator section of the About page. \n\n\n3.  I copied the example “Table Setup” code for one of the falcon tables. How can I customize the table?\nFor each table template page, next to the “Table Setup” tab is the “Function Details” tab. This tab contains information about each of the customizable parameters available for the table, and what the default settings for each are. If you require a customization option that is not available for a given table, please file a Feature Request issue on GitHub here. \n\n\n4.  I need a table that isn’t available on the falcon website. Can I request a table be added?\nThe falcon team is actively maintaining and adding new table functions to the package. If you would like an FDA safety table that is not listed on the falcon website, please file a New Table Template issue on GitHub here with the table number and the team will work on adding it to the package. \n\n\n5.  I don’t know the number of the FDA safety table I am interested in. Is there a list of tables by title?\nA list of all available tables by title is available on the Template Library Index page. \n\n\n\nOther Questions - Contact Us\nIf you have questions not listed above please contact us by filing an issue on GitHub here or reaching out to the falcon team directly via our Slack channel here."
  },
  {
    "objectID": "NEWS.html",
    "href": "NEWS.html",
    "title": "",
    "section": "",
    "text": "falcon 0.1.0.9051\n\nNew Features\n\nAdded new functions for creating standard FDA tables: make_table_02, make_table_03, make_table_04, make_table_05, make_table_06, make_table_07, make_table_08, make_table_09, make_table_10, make_table_11, make_table_12, make_table_13, make_table_14, make_table_15, make_table_16, make_table_17, make_table_18, make_table_20, make_table_21, make_table_32, make_table_33, make_table_34, make_table_35.\nAdded new functions for creating standard FDA figures: make_fig_01.\nAdded helper functions used within table functions:\n\nbasic_table_annot for adding basic table annotations (titles, footnotes, column counts).\nsplit_cols_by_arm for splitting columns by arm with option to add total column.\nalt_counts_df_preproc for pre-processing the alt_counts_df dataset.\nassert_flag_variables (internal) for checking that formatting is correct for flag variables in the data.\n\nAdded new functions for creating standard FDA tables using additional packages: make_table_02_tplyr, make_table_02_gtsum, make_table_09_gtsum, make_table_32_gtsum.\nAdded option to include risk difference columns in tables using the split_cols_by_arm function via the risk_diff argument.\nAdded risk difference functionality into relevant table-generating functions via the risk_diff argument.\n\n\n\nMiscellaneous\n\nInitialized the package.\nDeveloped Quarto website."
  },
  {
    "objectID": "LICENSE.html",
    "href": "LICENSE.html",
    "title": "",
    "section": "",
    "text": "Apache License\nVersion 2.0, January 2004 &lt;http://www.apache.org/licenses/&gt;\n\nTerms and Conditions for use, reproduction, and distribution\n\n1. Definitions\n“License” shall mean the terms and conditions for use, reproduction, and distribution as defined by Sections 1 through 9 of this document.\n“Licensor” shall mean the copyright owner or entity authorized by the copyright owner that is granting the License.\n“Legal Entity” shall mean the union of the acting entity and all other entities that control, are controlled by, or are under common control with that entity. For the purposes of this definition, “control” means (i) the power, direct or indirect, to cause the direction or management of such entity, whether by contract or otherwise, or (ii) ownership of fifty percent (50%) or more of the outstanding shares, or (iii) beneficial ownership of such entity.\n“You” (or “Your”) shall mean an individual or Legal Entity exercising permissions granted by this License.\n“Source” form shall mean the preferred form for making modifications, including but not limited to software source code, documentation source, and configuration files.\n“Object” form shall mean any form resulting from mechanical transformation or translation of a Source form, including but not limited to compiled object code, generated documentation, and conversions to other media types.\n“Work” shall mean the work of authorship, whether in Source or Object form, made available under the License, as indicated by a copyright notice that is included in or attached to the work (an example is provided in the Appendix below).\n“Derivative Works” shall mean any work, whether in Source or Object form, that is based on (or derived from) the Work and for which the editorial revisions, annotations, elaborations, or other modifications represent, as a whole, an original work of authorship. For the purposes of this License, Derivative Works shall not include works that remain separable from, or merely link (or bind by name) to the interfaces of, the Work and Derivative Works thereof.\n“Contribution” shall mean any work of authorship, including the original version of the Work and any modifications or additions to that Work or Derivative Works thereof, that is intentionally submitted to Licensor for inclusion in the Work by the copyright owner or by an individual or Legal Entity authorized to submit on behalf of the copyright owner. For the purposes of this definition, “submitted” means any form of electronic, verbal, or written communication sent to the Licensor or its representatives, including but not limited to communication on electronic mailing lists, source code control systems, and issue tracking systems that are managed by, or on behalf of, the Licensor for the purpose of discussing and improving the Work, but excluding communication that is conspicuously marked or otherwise designated in writing by the copyright owner as “Not a Contribution.”\n“Contributor” shall mean Licensor and any individual or Legal Entity on behalf of whom a Contribution has been received by Licensor and subsequently incorporated within the Work.\n\n\n2. Grant of Copyright License\nSubject to the terms and conditions of this License, each Contributor hereby grants to You a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare Derivative Works of, publicly display, publicly perform, sublicense, and distribute the Work and such Derivative Works in Source or Object form.\n\n\n3. Grant of Patent License\nSubject to the terms and conditions of this License, each Contributor hereby grants to You a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable (except as stated in this section) patent license to make, have made, use, offer to sell, sell, import, and otherwise transfer the Work, where such license applies only to those patent claims licensable by such Contributor that are necessarily infringed by their Contribution(s) alone or by combination of their Contribution(s) with the Work to which such Contribution(s) was submitted. If You institute patent litigation against any entity (including a cross-claim or counterclaim in a lawsuit) alleging that the Work or a Contribution incorporated within the Work constitutes direct or contributory patent infringement, then any patent licenses granted to You under this License for that Work shall terminate as of the date such litigation is filed.\n\n\n4. Redistribution\nYou may reproduce and distribute copies of the Work or Derivative Works thereof in any medium, with or without modifications, and in Source or Object form, provided that You meet the following conditions:\n\n(a) You must give any other recipients of the Work or Derivative Works a copy of this License; and\n(b) You must cause any modified files to carry prominent notices stating that You changed the files; and\n(c) You must retain, in the Source form of any Derivative Works that You distribute, all copyright, patent, trademark, and attribution notices from the Source form of the Work, excluding those notices that do not pertain to any part of the Derivative Works; and\n(d) If the Work includes a “NOTICE” text file as part of its distribution, then any Derivative Works that You distribute must include a readable copy of the attribution notices contained within such NOTICE file, excluding those notices that do not pertain to any part of the Derivative Works, in at least one of the following places: within a NOTICE text file distributed as part of the Derivative Works; within the Source form or documentation, if provided along with the Derivative Works; or, within a display generated by the Derivative Works, if and wherever such third-party notices normally appear. The contents of the NOTICE file are for informational purposes only and do not modify the License. You may add Your own attribution notices within Derivative Works that You distribute, alongside or as an addendum to the NOTICE text from the Work, provided that such additional attribution notices cannot be construed as modifying the License.\n\nYou may add Your own copyright statement to Your modifications and may provide additional or different license terms and conditions for use, reproduction, or distribution of Your modifications, or for any such Derivative Works as a whole, provided Your use, reproduction, and distribution of the Work otherwise complies with the conditions stated in this License.\n\n\n5. Submission of Contributions\nUnless You explicitly state otherwise, any Contribution intentionally submitted for inclusion in the Work by You to the Licensor shall be under the terms and conditions of this License, without any additional terms or conditions. Notwithstanding the above, nothing herein shall supersede or modify the terms of any separate license agreement you may have executed with Licensor regarding such Contributions.\n\n\n6. Trademarks\nThis License does not grant permission to use the trade names, trademarks, service marks, or product names of the Licensor, except as required for reasonable and customary use in describing the origin of the Work and reproducing the content of the NOTICE file.\n\n\n7. Disclaimer of Warranty\nUnless required by applicable law or agreed to in writing, Licensor provides the Work (and each Contributor provides its Contributions) on an “AS IS” BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied, including, without limitation, any warranties or conditions of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A PARTICULAR PURPOSE. You are solely responsible for determining the appropriateness of using or redistributing the Work and assume any risks associated with Your exercise of permissions under this License.\n\n\n8. Limitation of Liability\nIn no event and under no legal theory, whether in tort (including negligence), contract, or otherwise, unless required by applicable law (such as deliberate and grossly negligent acts) or agreed to in writing, shall any Contributor be liable to You for damages, including any direct, indirect, special, incidental, or consequential damages of any character arising as a result of this License or out of the use or inability to use the Work (including but not limited to damages for loss of goodwill, work stoppage, computer failure or malfunction, or any and all other commercial damages or losses), even if such Contributor has been advised of the possibility of such damages.\n\n\n9. Accepting Warranty or Additional Liability\nWhile redistributing the Work or Derivative Works thereof, You may choose to offer, and charge a fee for, acceptance of support, warranty, indemnity, or other liability obligations and/or rights consistent with this License. However, in accepting such obligations, You may act only on Your own behalf and on Your sole responsibility, not on behalf of any other Contributor, and only if You agree to indemnify, defend, and hold each Contributor harmless for any liability incurred by, or claims asserted against, such Contributor by reason of your accepting any such warranty or additional liability.\nEND OF TERMS AND CONDITIONS\n\n\n\nAPPENDIX: How to apply the Apache License to your work\nTo apply the Apache License to your work, attach the following boilerplate notice, with the fields enclosed by brackets [] replaced with your own identifying information. (Don’t include the brackets!) The text should be enclosed in the appropriate comment syntax for the file format. We also recommend that a file or class name and description of purpose be included on the same “printed page” as the copyright notice for easier identification within third-party archives.\nCopyright [yyyy] [name of copyright owner]\n\nLicensed under the Apache License, Version 2.0 (the \"License\");\nyou may not use this file except in compliance with the License.\nYou may obtain a copy of the License at\n\n  http://www.apache.org/licenses/LICENSE-2.0\n\nUnless required by applicable law or agreed to in writing, software\ndistributed under the License is distributed on an \"AS IS\" BASIS,\nWITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\nSee the License for the specific language governing permissions and\nlimitations under the License."
  }
]